Cambrex 10-K 11 Feb 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Jan. 31, 2014	Jun. 30, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'CAMBREX CORP	'	'
Entity Central Index Key	'0000820081	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Filer Category	'Accelerated Filer	'	'
Entity Public Float	'	'	$410,339,343
Entity Common Stock, Shares Outstanding	'	30,485,265	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Dec-13	'	'

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$22,745	$23,551
Trade receivables, less allowances of $1,058 and $652 at respective dates	71,276	43,094
Other receivables	12,943	2,015
Inventories, net	89,965	71,221
Prepaid expenses and other current assets	5,631	4,089
Total current assets	202,560	143,970
Property, plant and equipment, net	171,966	151,815
Goodwill	38,670	37,312
Intangible assets, net	4,011	4,091
Investments in and advances to partially-owned affiliates	13,364	15,094
Deferred income taxes	19,799	30,786
Other non-current assets	7,667	2,663
Total assets	458,037	385,731
Current liabilities:	'	'
Accounts payable	29,052	27,612
Deferred revenue	20,121	11,570
Accrued expenses and other current liabilities	48,098	43,301
Total current liabilities	97,271	82,483
Long-term debt	79,250	64,000
Deferred income taxes	12,835	10,383
Accrued pension benefits	40,123	55,373
Other non-current liabilities	18,338	10,195
Total liabilities	247,817	222,434
Commitments and contingencies (see Notes 18 and 19)	'	'
Stockholders' equity:	'	'
Common Stock, $.10 par value; authorized 100,000,000 issued 32,240,795 and 31,704,230 shares at respective dates	3,223	3,169
Additional paid-in capital	109,765	104,173
Retained earnings	131,178	105,263
Treasury stock, at cost, 1,757,530 and 1,795,082 shares at respective dates	-14,984	-15,217
Accumulated other comprehensive loss	-18,962	-34,091
Total stockholders' equity	210,220	163,297
Total liabilities and stockholders' equity	$458,037	$385,731

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, except Share data, unless otherwise specified
Current assets:	'	'
Trade receivables, allowance for doubtful accounts	$1,058	$652
Stockholders' equity:	'	'
Common Stock, par value (in dollars per share)	$0.10	$0.10
Common Stock, shares authorized (in shares)	100,000,000	100,000,000
Common Stock, shares issued (in shares)	32,240,795	31,704,230
Treasury stock, at cost (in shares)	1,757,530	1,795,082

CONSOLIDATED_INCOME_STATEMENTS

CONSOLIDATED INCOME STATEMENTS (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
CONSOLIDATED INCOME STATEMENTS [Abstract]	'	'	'
Gross Sales	$317,212	$277,931	$254,475
Commissions, allowances and rebates	1,351	2,503	1,776
Net sales	315,861	275,428	252,699
Other	2,315	1,073	2,954
Net revenues	318,176	276,501	255,653
Cost of goods sold	215,272	186,014	181,569
Gross profit	102,904	90,487	74,084
Selling, general and administrative expenses	47,568	45,248	39,227
Research and development expenses	10,387	9,544	11,037
Total operating expenses	57,955	54,792	50,264
Gain on sale of asset	4,680	0	0
Operating profit	49,629	35,695	23,820
Other expenses/(income)	'	'	'
Interest expense, net	2,242	2,439	2,373
Other expenses/(income), net	118	122	-111
Equity in losses of partially-owned affiliates	2,262	1,766	1,621
Income before income taxes	45,007	31,368	19,937
Provision/(benefit) for income taxes	14,732	-31,861	6,202
Income from continuing operations	30,275	63,229	13,735
Loss from discontinued operations, net of tax	-4,360	-926	-2,767
Net income	$25,915	$62,303	$10,968
Basic earnings per share	'	'	'
Income from continuing operations (in dollars per share)	$1	$2.13	$0.46
Loss from discontinued operations, net of tax (in dollars per share)	($0.14)	($0.03)	($0.09)
Net income (in dollars per share)	$0.86	$2.10	$0.37
Diluted earnings per share	'	'	'
Income from continuing operations (in dollars per share)	$0.98	$2.09	$0.46
Loss from discontinued operations, net of tax (in dollars per share)	($0.14)	($0.03)	($0.09)
Net income (in dollars per share)	$0.84	$2.06	$0.37
Weighted average shares outstanding:	'	'	'
Basic weighted average shares outstanding (in shares)	30,150	29,703	29,468
Effect of dilutive stock based compensation (in shares)	751	611	96
Diluted weighted average shares outstanding (in shares)	30,901	30,314	29,564

STATEMENTS_OF_CONSOLIDATED_COM

STATEMENTS OF CONSOLIDATED COMPREHENSIVE INCOME/(LOSS) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net income	$25,915	$62,303	$10,968
Foreign currency translation adjustments:	'	'	'
Unrealized net change arising during the period	4,813	4,066	-7,501
Comprehensive income/(loss)	41,044	59,799	-8,727
Foreign Currency Forward Contracts [Member]	'	'	'
Derivatives and Hedging instruments [Abstract]	'	'	'
Unrealized net (loss)/gain	0	-51	624
Reclassification adjustments for (gains)/losses included in net income	0	-329	-143
Income taxes	0	110	-142
Interest Rate Swap Agreement [Member]	'	'	'
Derivatives and Hedging instruments [Abstract]	'	'	'
Unrealized net (loss)/gain	-130	-1,253	0
Reclassification adjustments for (gains)/losses included in net income	444	323	0
Income taxes	-110	326	0
Pension Plans [Member]	'	'	'
Actuarial gain/loss [Abstract]	'	'	'
Actuarial gain/(loss) arising during the period	13,651	-4,413	-14,126
Amortization to net income of net actuarial loss	1,339	1,140	618
Prior service cost [Abstract]	'	'	'
Amortization to net income of net prior service cost	50	110	486
Other Comprehensive (Income) Loss, Pension and other Postretirement Benefit Plans, Tax [Abstract]	'	'	'
Income taxes	($4,928)	($2,533)	$489

CONSOLIDATED_STATEMENTS_OF_STO

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Loss [Member]	Total
In Thousands, except Share data, unless otherwise specified
Balance at Dec. 31, 2010	$3,140	$101,271	$31,992	($16,876)	($11,892)	$107,635
Balance (in shares) at Dec. 31, 2010	31,409,638	'	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'	'
Net income	'	'	10,968	'	'	10,968
Other comprehensive income/(loss)	'	'	'	'	-19,695	-19,695
Exercise of stock options	3	142	'	'	'	145
Exercise of stock options (in shares)	31,500	'	'	'	'	'
Deferred compensation	'	-28	'	80	'	52
Vested restricted stock	'	-911	'	911	'	0
Vested performance stock	'	-393	'	393	'	0
Stock option expense	'	1,028	'	'	'	1,028
Restricted stock expense	'	497	'	'	'	497
Performance stock expense	'	40	'	'	'	40
Repurchase of shares	'	'	'	-329	'	-329
Balance at Dec. 31, 2011	3,143	101,646	42,960	-15,821	-31,587	100,341
Balance (in shares) at Dec. 31, 2011	31,441,138	'	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'	'
Net income	'	'	62,303	'	'	62,303
Other comprehensive income/(loss)	'	'	'	'	-2,504	-2,504
Exercise of stock options	26	1,329	'	'	'	1,355
Exercise of stock options (in shares)	263,092	'	'	'	'	'
Vested restricted stock	'	-604	'	604	'	0
Stock option expense	'	1,303	'	'	'	1,303
Restricted stock expense	'	446	'	'	'	446
Performance stock expense	'	53	'	'	'	53
Balance at Dec. 31, 2012	3,169	104,173	105,263	-15,217	-34,091	163,297
Balance (in shares) at Dec. 31, 2012	31,704,230	'	'	'	'	31,704,230
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'	'
Net income	'	'	25,915	'	'	25,915
Other comprehensive income/(loss)	'	'	'	'	15,129	15,129
Exercise of stock options	54	3,170	'	'	'	3,224
Exercise of stock options (in shares)	536,565	'	'	'	'	'
Vested restricted stock	'	-534	'	534	'	0
Stock option expense	'	1,994	'	'	'	1,994
Restricted stock expense	'	427	'	'	'	427
Performance stock expense	'	404	'	'	'	404
Share based compensation tax windfall	'	131	'	'	'	131
Repurchase of shares	'	'	'	-301	'	-301
Balance at Dec. 31, 2013	$3,223	$109,765	$131,178	($14,984)	($18,962)	$210,220
Balance (in shares) at Dec. 31, 2013	32,240,795	'	'	'	'	32,240,795

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:	'	'	'
Net income	$25,915	$62,303	$10,968
Adjustments to reconcile net income to cash flows:	'	'	'
Depreciation and amortization	22,473	21,775	23,120
Non-cash deferred revenue	-10,093	-238	-973
Increase in inventory reserve	2,329	2,790	1,637
Gain on sale of assets	-4,281	-5	25
Allowance for doubtful accounts	433	193	-103
Stock based compensation included in net income	2,825	1,802	1,565
Deferred income tax provision	5,902	-40,712	-721
Equity in losses of partially-owned affiliates	2,262	1,766	1,621
Other	348	348	365
Changes in assets and liabilities:	'	'	'
Trade receivables	-27,707	-6,310	2,066
Inventories	-19,328	-10,295	-3,523
Prepaid expenses and other current assets	-2,651	-188	729
Accounts payable and other current liabilities	10,107	3,134	6,247
Deferred revenue	18,644	10,748	1,497
Other non-current assets and liabilities	11,229	182	-5,597
Discontinued operations:	'	'	'
Net cash used in discontinued operations	-1,533	-3,747	-601
Net cash provided by operating activities	36,874	43,546	38,322
Cash flows from investing activities:	'	'	'
Capital expenditures	-57,320	-18,156	-15,008
Proceeds from sale of assets	2,378	16	20
Advances to partially-owned affiliates	-1,655	-2,047	0
Acquisition of business and equity investment, net of cash acquired	0	0	-500
Other	0	5	0
Net cash used in investing activities	-56,597	-20,182	-15,488
Long-term debt activity (including current portion):	'	'	'
Borrowings	70,950	5,500	105,800
Repayments	-55,700	-39,500	-123,700
Debt issuance costs	0	0	-1,541
Proceeds from stock options exercised	3,224	1,355	145
Other	-301	-22	-340
Net cash provided by/(used in) financing activities	18,173	-32,667	-19,636
Effect of exchange rate changes on cash and cash equivalents	744	933	-891
Net (decrease)/increase in cash and cash equivalents	-806	-8,370	2,307
Cash and cash equivalents at beginning of year	23,551	31,921	29,614
Cash and cash equivalents at end of year	22,745	23,551	31,921
Supplemental disclosure:	'	'	'
Interest paid, net of capitalized interest	2,325	2,556	2,258
Income taxes paid, net of refunds received	$7,211	$5,068	$8,520

The_Company

The Company	12 Months Ended
	Dec. 31, 2013
The Company [Abstract]	'
The Company	'
	-1	The Company
	Cambrex Corporation and Subsidiaries (the “Company” or “Cambrex”) primarily provides products and services worldwide to pharmaceutical companies and generic drug companies. The Company is dedicated to accelerating its customers’ drug discovery, development and manufacturing processes for human therapeutics. The Company’s products consist of active pharmaceutical ingredients (“APIs”) and pharmaceutical intermediates produced under Food and Drug Administration current Good Manufacturing Practices for use in the production of prescription and over-the-counter drug products. Cambrex has three operating segments, which are manufacturing facilities that have been aggregated as one reportable segment.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	-2	Summary of Significant Accounting Policies
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Equity investments in which the Company exercises significant influence but does not control, are accounted for using the equity method. The Company’s share of its equity method investees’ earnings or losses are included in “Other expenses/(income)” in the income statements. The Company eliminates its pro rata share of gross profit on sales with its equity method investees for assets still remaining in inventory at the end of the reporting period. All other significant intercompany balances and transactions have been eliminated in consolidation.
	Cash Equivalents
	Temporary cash investments with an original maturity of less than three months are considered cash equivalents. The carrying amounts approximate fair value.
	Allowance for Doubtful Accounts
	The Company maintains allowances for doubtful accounts relating to estimated losses resulting from customers being unable to make required payments. Allowances for doubtful accounts are based on historical experience and known factors regarding specific customers and the industries in which those customers operate. If the financial condition of the Company’s customers were to deteriorate, resulting in their inability to make payments, additional allowances would be required.
	Concentrations of credit risk
	Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. In the normal course of business, the Company maintains cash balances with European Union banks ranging from $5,000 - $15,000. The Company routinely monitors the risks associated with these institutions and diversifies its exposure by maintaining smaller balances with multiple financial institutions. Concentrations of credit risk with respect to accounts receivable are limited due to the Company's large number of customers and their dispersion throughout the world.
	Derivative Instruments
	Derivative financial instruments are periodically used by the Company primarily for hedging purposes to mitigate a variety of working capital, investment and borrowing risks. The Company primarily uses foreign currency forward contracts to minimize foreign currency exchange rate risk associated with foreign currency transactions. Gains and losses on these hedging transactions are generally recorded in earnings in the same period as they are realized, which is usually the same period as the settlement of the underlying transactions. The Company uses interest rate swap instruments only as hedges. As such, the differential to be paid or received in connection with these instruments is accrued and recognized in income as an adjustment to interest expense.
	The Company formally documents the relationship between hedging instruments and hedged items, as well as its risk management objectives and strategies for undertaking various hedging relationships. All cash flow hedges are linked to transactions and the Company assesses effectiveness at inception and on a quarterly basis. If it is determined that a derivative instrument is not highly effective or the transaction is no longer deemed probable of occurring, the Company discontinues hedge accounting and recognizes the ineffective portion in current period earnings.
	Inventories
	Inventories are stated at the lower of cost, determined on a first‑in, first‑out basis, or market. The determination of market value involves assessment of numerous factors, including estimated selling prices. Reserves are recorded to reduce the carrying value for inventory determined to be damaged, obsolete or otherwise unsaleable.
	Property, Plant and Equipment
	Property, plant and equipment is stated at cost, net of accumulated depreciation. Plant and equipment are depreciated on a straight‑line basis over the estimated useful lives for each applicable asset group as follows:
	Buildings and improvements		20 to 30 years, or term of lease if applicable
	Machinery and equipment		7 to 15 years
	Furniture and fixtures		5 to 7 years
	Computer hardware and software		3 to 7 years
	Expenditures for additions, major renewals or betterments are capitalized and expenditures for maintenance and repairs are charged to income as incurred.
	When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in costs of goods sold or operating expenses. Interest is capitalized in connection with the construction and acquisition of assets that are capitalized over longer periods of time for larger amounts. The capitalized interest is recorded as part of the cost of the asset to which it relates and is amortized over the asset’s estimated useful life. Total interest capitalized in connection with ongoing construction activities was $298 in 2013 and negligible in both 2012 and 2011.
	Impairment of Goodwill
	The Company reviews the carrying value of goodwill to determine whether impairment may exist on an annual basis or whenever it has reason to believe goodwill may not be recoverable. The annual impairment test of goodwill is performed during the fourth quarter of each fiscal year. The Company did not have an impairment for any of the years presented.
	Goodwill impairment is determined using a two-step process. The first step of the goodwill impairment test is used to identify potential impairment by comparing the fair value of each reporting unit, determined using various valuation techniques, with the primary technique being a discounted cash flow analysis, to its carrying value. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered not impaired and the second step of the impairment test is unnecessary. If the carrying amount of a reporting unit exceeds its fair value, the second step of the goodwill impairment test is performed to measure the amount of impairment loss, if any. The second step of the goodwill impairment test compares the implied fair value of the reporting unit’s goodwill with the carrying amount of that goodwill. If the carrying amount of the reporting unit’s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to that excess.
	Impairment of Long-Lived Assets
	The Company assesses the impairment of its long-lived assets, including amortizable intangible assets, and property, plant and equipment, whenever economic events or changes in circumstances indicate that the carrying amounts of the assets may not be recoverable. Long lived assets are considered to be impaired when the sum of the undiscounted expected future operating cash flows is less than the carrying amounts of the related assets. If impaired, the assets are written down to fair market value.
	The Company has investments in partially-owned affiliates. It does not separately test an investee’s underlying assets for impairment but will recognize its share of any impairment charge recorded by an investee in earnings and consider the effect of the impairment on its investment. A series of operating losses of an investee or other factors may indicate that a decrease in value of the investment has occurred that is other than temporary. A loss in value of an investment that is other than a temporary decline would be recognized as an impairment if the fair value of that investment is less than its carrying amount.
	Revenue Recognition
	Revenues are generally recognized when title to products and risk of loss are transferred to customers. Additional conditions for recognition of revenue are that collection of sales proceeds is reasonably assured and the Company has no further performance obligations.
	Amounts billed in advance are recorded as deferred revenue on the balance sheet. Since payments received are sometimes non-refundable, the termination of a contract by a customer prior to its completion could result in an immediate recognition of deferred revenue relating to payments already received but not previously recognized as revenue.
	Sales terms to certain customers include rebates if certain conditions are met. Additionally, sales are generally made with a limited right of return under certain conditions. The Company estimates these rebates and returns at the time of sale based on the terms of agreements with customers and historical experience and recognizes revenue net of these estimated costs which are classified as allowances and rebates.
	The Company bills a portion of freight cost incurred on shipments to customers. Amounts billed to customers are recorded within net revenues. Freight costs are reflected in cost of goods sold.
	Income Taxes
	The Company and its eligible subsidiaries file a consolidated U.S. income tax return. Foreign subsidiaries are consolidated for financial reporting but are not eligible to be included in the consolidated U.S. income tax return, however the earnings of foreign subsidiaries are generally taxed by the U.S. when repatriated and such U.S. tax may be reduced or eliminated by federal foreign tax credits based on the foreign income and withholding taxes paid or accrued by the foreign subsidiary. Historically, the Company intended to reinvest foreign earnings indefinitely outside of the U.S. and only considered repatriating excess cash from foreign subsidiaries if it could utilize fully valued domestic tax attributes to completely offset any tax expense that would otherwise result. Unrecognized foreign tax credits and fully valued foreign tax credit carryovers were available to offset any potential U.S. tax liability. Therefore, the Company had not provided U.S. federal income taxes or foreign withholding taxes on its undistributed earnings from foreign operations prior to 2012. During the fourth quarter of 2012 the Company completed a detailed forecast of foreign source income by jurisdiction as part of the ongoing process to evaluate its valuation allowance against deferred tax assets. As part of this process, as well as a continuing desire to limit its credit and currency exposure for cash held in foreign currencies or in non-U.S. banks, the Company determined that it is likely that a portion of the undistributed earnings of its foreign subsidiaries will be repatriated to the U.S. in the future. Accordingly, the Company changed its indefinite reinvestment assertion and has provided a deferred tax liability of $568 on undistributed foreign earnings as of December 31, 2013. Subject to limitations, U.S. income tax on such foreign earnings, when actually repatriated, may be reduced or eliminated by unrecognized foreign tax credits that may be generated in connection with the repatriation, or by existing foreign tax credits or other tax attributes for which valuation allowance was released in the fourth quarter of 2012. The Company monitors available evidence and management’s plans for foreign earnings and expects to continue to provide deferred tax expense based on the tax liability that would be due upon repatriation of amounts not considered permanently reinvested.
	Use of Estimates
	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Environmental Costs
	The Company is subject to extensive and changing federal, state, local and foreign environmental laws and regulations, and has made provisions for the estimated financial impact of environmental activities. The Company’s policy is to accrue environmental related costs of a non-capital nature, including estimated litigation costs, when those costs are believed to be probable and can be reasonably estimated. The quantification of environmental exposures requires an assessment of many factors, including changing laws and regulations, advancements in environmental technologies, the quality of information available related to specific sites, the assessment stage of each site investigation, preliminary findings and the length of time involved in remediation or settlement. Such accruals are adjusted as further information develops or circumstances change. For certain matters, the Company expects to share costs with other parties. Recoveries of environmental remediation costs from other parties are recorded as assets when their receipt is deemed certain.
	Foreign Currency
	The functional currency of the Company's foreign subsidiaries is the applicable local currency. The translation of the applicable foreign currencies into U.S. dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for revenue and expense accounts and cash flows using average rates of exchange prevailing during the year. Adjustments resulting from the translation of foreign currency financial statements are accumulated in a separate component of stockholders' equity until the entity is sold or substantially liquidated. Gains or losses relating to transactions of a long-term investment nature are accumulated in stockholders' equity. Gains or losses resulting from third-party foreign currency transactions are included in the income statement as a component of other revenues in the consolidated income statement. Foreign currency net transaction losses were $133, $274 and $62 in 2013, 2012 and 2011, respectively.
	Earnings per Common Share
	All diluted earnings per share are computed on the basis of the weighted average shares of common stock outstanding plus common equivalent shares arising from the effect of dilutive stock options, equity-settled performance shares and restricted stock units, using the treasury stock method.
	For the years ended December 31, 2013, 2012 and 2011, shares of 916,350, 580,745, and 1,839,373, respectively, were not included in the calculation of diluted shares outstanding because the effect would be anti-dilutive.
	Comprehensive Income/(Loss)
	Included within accumulated other comprehensive income/(loss) for the Company are foreign currency translation adjustments, changes in the fair value related to derivative instruments classified as cash flow hedges, net of related tax, and changes in the pensions, net of tax. Total comprehensive income/(loss) for the years ended December 31, 2013 and 2012 are included in the Statements of Comprehensive Income/(Loss).
	The components of accumulated other comprehensive loss in stockholders’ equity are as follows:
			2013			2012
	Foreign currency translation		$	9,990		$	5,177
	Unrealized loss on hedging contracts, net of tax			(396	)		(600	)
	Pensions, net of tax			(28,556	)		(38,668	)
	Total		$	(18,962	)	$	(34,091	)
	Reclassification
	Certain reclassifications have been made to prior year amounts to conform with current year presentation.

Impact_of_Recently_Issued_Acco

Impact of Recently Issued Accounting Pronouncements	12 Months Ended
	Dec. 31, 2013
Impact of Recently Issued Accounting Pronouncements [Abstract]	'
Impact of Recently Issued Accounting Pronouncements	'
	-3	Impact of Recently Issued Accounting Pronouncements
	Comprehensive Income
	In February 2012, the FASB issued “Comprehensive Income: Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income (“AOCI”)” which improves the reporting of reclassifications out of AOCI. The amendment requires an entity to report the effect of significant reclassifications out of AOCI on the respective line items in net income. For other amounts not required to be reclassified to net income, an entity is required to cross-reference other disclosures required under U.S. GAAP that provide additional detail about these amounts. This amendment became effective January 1, 2013 and the effect of adopting this updated guidance did not have an impact on the Company’s financial position or results of operations.
	Presentation of Unrecognized Tax Benefits
	In July 2013, the FASB issued “Income Taxes: Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists” which improves the reporting of unrecognized tax benefits. The amendment requires an entity to present an unrecognized tax benefit as a reduction to deferred tax assets for NOLs or tax credit carryforwards, unless the NOL or tax credit carryforward is not available under the tax law or not intended to be used as of the reporting date to settle any additional income taxes that would be due from the disallowance of a tax position. Under that exception, the unrecognized tax benefit should be presented as a liability instead of being netted against deferred tax assets for NOLs or tax credit carryforwards. This amendment is effective for fiscal quarters and years beginning after December 15, 2013. The Company adopted this updated guidance early and it did not have an impact on the Company’s financial position or results of operations.

Net_Inventories

Net Inventories	12 Months Ended
	Dec. 31, 2013
Net Inventories [Abstract]	'
Net Inventories	'
	-4	Net Inventories
	Inventories are stated at the lower of cost, determined on a first-in, first-out basis, or market.
	Net inventories consist of the following:
			December 31,
			2013		2012
	Finished goods		$	29,797	$	30,262
	Work in process			31,990		23,533
	Raw materials			22,580		12,352
	Supplies			5,598		5,074
	Total		$	89,965	$	71,221
	The components of inventory stated above are net of reserves of $11,496 and $11,839 as of December 31, 2013 and 2012, respectively.

Property_Plant_and_Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment	'
	-5	Property, Plant and Equipment
	Property, plant and equipment consist of the following:
			December 31,
			2013			2012
	Land		$	4,312		$	4,221
	Buildings and improvements			108,460			92,307
	Machinery and equipment			398,490			364,370
	Furniture and fixtures			1,884			1,813
	Construction in progress			16,808			21,382
	Total			529,954			484,093
	Accumulated depreciation			(357,988	)		(332,278	)
	Net		$	171,966		$	151,815
	Depreciation expense was $22,218, $21,528 and $22,822 for the years ended December 31, 2013, 2012 and 2011, respectively. Total capital expenditures in 2013 and 2012 were $41,600 and $29,407, respectively.

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets [Abstract]	'
Goodwill and Intangible Assets	'
	-6	Goodwill and Intangible Assets
	The changes in the carrying amount of goodwill for the years ended December 31, 2013 and 2012 are as follows:
	Balance as of December 31, 2011		$	36,731
	Translation effect			581
	Balance as of December 31, 2012			37,312
	Translation effect			1,358
	Balance as of December 31, 2013		$	38,670
	Acquired intangible assets, which are amortized, consist of the following:
					As of December 31, 2013
			Amortization Period				Accumulated Amortization			Net Carrying Amount
					Gross Carrying Amount
	Technology-based intangibles		20 years		$	4,192	$	(786	)	$	3,406
	Customer-related intangibles		10 - 15 years			814		(209	)		605
					$	5,006	$	(995	)	$	4,011
					As of December 31, 2012
			Amortization Period				Accumulated Amortization			Net Carrying Amount
					Gross Carrying Amount
	Technology-based intangibles		20 years		$	4,011	$	(552	)	$	3,459
	Customer-related intangibles		10 - 15 years			778		(146	)		632
					$	4,789	$	(698	)	$	4,091
	The change in the gross carrying amount is due to the impact of foreign currency.
	Amortization expense amounted to $255, $247 and $298 for the years ended December 31, 2013, 2012 and 2011, respectively.
	Amortization expense related to current intangible assets is expected to be approximately $265 in each of the next five years.

Investments_in_and_Advances_to

Investments in and Advances to Partially-Owned Affiliates	12 Months Ended
	Dec. 31, 2013
Investments in and Advances to Partially-Owned Affiliates [Abstract]	'
Investments in and Advances to Partially-Owned Affiliates	'
	-7	Investments in and Advances to Partially-Owned Affiliates
	The Company owns 51% of the equity in Zenara Pharma (“Zenara”) and will purchase the remaining 49% in 2016 based upon a formula derived from future EBITDA. Zenara is a pharmaceutical company focused on the formulation of final dosage form products based in India.
	Under current U.S. GAAP, the Company does not consolidate the results of Zenara as it does not meet the requirements of having control over the entity. The contractual arrangement includes substantial participating rights for the 49% interest holder. These rights were bargained for by the 49% interest holder to ensure that all significant transactions, as defined in the agreement, require a unanimous vote. Furthermore, the 49% minority owner manages all daily operations of the business including employee relations at the site. Therefore, the Company accounts for this investment under the equity method of accounting.
	The impact of its ownership stake in Zenara was a loss of $1,956, $1,976 and $1,621 in 2013, 2012 and 2011, respectively, and is located within “Other expenses/(income)” as “Equity in losses of partially-owned affiliates” in the Company’s income statement. These amounts include amortization expense of $882, $965 and $1,106 in 2013, 2012 and 2011, respectively, and depreciation expense of $130, $132 and $149 in 2013, 2012 and 2011, respectively. The Company advanced $1,514 and $1,594 to Zenara in 2013 and 2012, respectively.
	Investments in and advances to partially-owned affiliates also includes a loss of $311 and a gain of $210 in 2013 and 2012, respectively, related to an investment in a European joint venture. In 2013 and 2012, the Company advanced $141 and $453, respectively to the European joint venture.

Accrued_Expense_and_Other_Curr

Accrued Expense and Other Current Liabilities	12 Months Ended
	Dec. 31, 2013
Accrued Expenses And Other Current Liabilities [Abstract]	'
Accrued Expenses and Other Current Liabilities	'
	-8	Accrued Expense and Other Current Liabilities
	The components of accrued expenses and other current liabilities are as follows:
			December 31,
			2013		2012
	Salaries and employee benefits payable		$	26,211	$	23,882
	Taxes payable and related reserves			10,168		9,637
	Other			11,719		9,782
	Total		$	48,098	$	43,301

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Taxes [Abstract]	'
Income Taxes	'
	-9	Income Taxes
	Income before income taxes consists of the following:
			December 31,
			2013			2012			2011
	Domestic		$	23,068		$	13,525		$	3,749
	International			21,939			17,843			16,188
	Total		$	45,007		$	31,368		$	19,937
	The provision for income taxes consist of the following provisions/(benefits):
			December 31,
			2013			2012			2011
	Current:
	Federal		$	630		$	(177	)	$	(196	)
	State			15			4			45
	International			5,980			8,525			7,074
				6,625			8,352			6,923
	Deferred:
	Federal		$	7,014		$	(36,287	)	$	204
	International			1,093			(3,926	)		(925	)
				8,107			(40,213	)		(721	)
	Total		$	14,732		$	(31,861	)	$	6,202
	The provision/(benefit) for income taxes differs from the statutory federal income tax rate of 35% for 2013, 2012 and 2011 as follows:
			December 31,
			2013			2012			2011
	Income tax provision at U.S federal statutory rate		$	15,752		$	10,979		$	6,978
	Effect of foreign income taxed at rates other than the U.S. federal statutory rate			242			(451	)		469
	Foreign income inclusions			-			4,563			8,398
	Tax credits			(250	)		(177	)		(196	)
	Changes in tax laws			(1,155	)		(1,329	)		-
	Indefinite-lived intangibles			-			-			204
	Net change in valuation allowance			(97	)		(45,105	)		(9,546	)
	Other			240			(341	)		(105	)
	Total		$	14,732		$	(31,861	)	$	6,202
	Foreign income inclusions represent distributions from foreign subsidiaries which gave rise to newly recognized foreign tax credits. The Company utilized fully valued foreign tax credits, alternative minimum tax credits, and research and experimentation tax credits in 2012, prior to the release of the domestic valuation allowance and fully valued foreign tax credits in 2011 to completely offset any tax impact of the foreign income inclusions. Net change in the valuation allowance in 2012 includes the fourth quarter benefit of $36,287 for the release of the domestic valuation allowance, the reduction in the domestic valuation allowance, prior to the release, for the utilization of fully valued tax credits to offset U.S. income tax and deferred tax amounts of $8,660, and the reduction in the foreign valuation allowance of $158.
	The components of deferred tax assets and liabilities as of December 31, 2013 and 2012 relate to temporary differences and carryforwards as follows:
			December 31,
			2013			2012
	Deferred tax assets:
	Inventory		$	2,510		$	2,263
	Legal and related reserves			260			100
	Foreign tax credit carryforwards			31,463			35,410
	Environmental			2,995			850
	Net capital loss carryforwards (domestic)			31			31
	Net operating loss carryforwards (foreign)			944			902
	Employee benefits			12,841			17,977
	Restructuring			239			334
	Research & experimentation tax credit carryforwards			1,900			1,681
	Alternative minimum tax credit carryforwards			2,773			2,604
	Property, plant and equipment			3,843			4,228
	Other			3,507			4,553
	Total gross deferred tax assets			63,306			70,933
	Valuation allowance			(29,890	)		(29,941	)
	Total deferred tax assets		$	33,416		$	40,992
	Deferred tax liabilities:
	Property, plant and equipment			(9,059	)		(6,523	)
	Intangibles and other			(9,856	)		(9,510	)
	Unremitted foreign earnings			(568	)		(541	)
	Foreign tax allocation reserve			(2,006	)		(2,544	)
	Other			(2,187	)		(2	)
	Total deferred tax liabilities		$	(23,676	)	$	(19,120	)
	Net deferred tax asset / (liability)		$	9,740		$	21,872
	Classified as follows in the consolidated balance sheet:
	Current deferred tax asset (included in other current assets)			2,874			1,469
	Non-current deferred tax asset			19,799			30,786
Current deferred tax liability (included in other current liabilities)			(98	)		-
Non-current deferred tax liability			(12,835	)		(10,383	)
		$	9,740		$	21,872
The Company establishes a valuation allowance against deferred tax assets when it is more likely than not that the Company will be unable to realize those deferred tax assets in the future. In 2003, the Company’s assessment of the need for a valuation allowance against domestic deferred tax assets considered current and past performance, cumulative losses in recent years from domestic operations, and a shift in the geographic mix of forecasted income. Considering the pattern of then-recent domestic losses, the Company gave significant weight to projections showing future domestic losses for purposes of assessing the need for a valuation allowance. This assessment resulted in a determination that it was more likely than not that domestic deferred tax assets would not be realized, and as such, a valuation allowance against net domestic deferred tax assets was recorded.
A sustained period of domestic profitability along with expectations of future domestic profitability of sufficient amounts and character was required before the Company concluded that it was more likely than not that the domestic deferred tax assets would be realized, and as such, that there was no longer the need for a full valuation allowance against net domestic deferred tax assets. During 2012, the Company concluded that its three-year cumulative domestic profitability through the end of 2012 and expectations of future domestic profitability warranted the reversal of all of the domestic valuation allowance attributable to net federal temporary differences, alternative minimum tax credits, and research and experimentation tax credits. Additionally, the Company released a portion of the domestic valuation allowance attributable to federal foreign tax credits. These valuation allowance releases resulted in a tax benefit to continuing operations of $36,287.
The Company expects to maintain a partial valuation allowance against its domestic federal foreign tax credits, subject to the consideration of all prudent and feasible tax planning strategies, until such time as the Company attains an appropriate level of future domestic profitability of the appropriate character and in the appropriate taxable years and is able to conclude that it is more likely than not that some portion of the domestic federal foreign tax credits against which the valuation allowance is recorded are realizable. It is possible that additional domestic valuation allowance attributable to federal foreign tax credits could be released in the future. The Company currently expects to maintain a full valuation allowance against state tax credits and deferred tax assets due to restrictive rules regarding realization. The Company expects to maintain a full valuation allowance against certain foreign tax assets, primarily NOL carryforwards, until such time as the Company attains an appropriate level of future profitability in the appropriate jurisdictions and is able to conclude that it is more likely than not that its foreign deferred tax assets are realizable.
The domestic valuation allowance for the years ended December 31, 2013, 2012 and 2011 decreased $3, decreased $47,490 and increased $304, respectively. The 2013 decrease in the domestic valuation allowance is due to domestic state items. The 2012 decrease in the domestic valuation allowance was allocated as follows: The valuation allowance decreased $36,287 for the release of valuation allowance due to domestic profitability, decreased by a net amount of $8,660 for domestic income and deferred tax amounts in continuing operations prior to the release of valuation allowance in the fourth quarter of 2012, and decreased by a net amount of $2,543 for domestic gains and losses included in OCI and discontinued operations. The 2011 increase in the domestic valuation allowance was allocated as follows: The valuation allowance decreased $9,340 for domestic income in continuing operations and increased by a net amount of $9,644 for deferred tax amounts, domestic gains and losses included in OCI and discontinued operations.
The foreign valuation allowance for the years ended December 31, 2013, 2012 and 2011 decreased $48, $140, and $582, respectively. The 2013 decrease in the foreign valuation allowance was allocated as follows: The valuation allowance decreased $94 for foreign income and increased $46 for deferred tax amounts and currency translation adjustments included in OCI. The 2012 decrease in the foreign valuation allowance was allocated as follows: The valuation allowance decreased $158 for foreign income and increased $18 for deferred tax amounts and currency translation adjustments included in OCI. The 2011 decrease in the foreign valuation allowance was allocated as follows: The valuation allowance decreased $206 for foreign income and decreased $376 for deferred tax amounts and currency translation adjustments included in OCI.
Under the tax laws of the various jurisdictions in which the Company operates, NOLs may be carried forward or back, subject to statutory limitations, to reduce taxable income in future or prior years. Foreign NOLs are approximately $3,356, of which $2,090 are attributable to NOLs acquired during 2010. NOLs in most foreign jurisdictions will carry forward indefinitely.
As of December 31, 2013, $31,463 of domestic federal foreign tax credits, $1,900 of research and experimentation tax credits and $2,773 of alternative minimum tax credits are available as credits against future U.S. income taxes on worldwide income, subject to certain limitations. Under U.S. tax laws, these will expire in 2013 through 2018, 2020 through 2033, and the alternative minimum tax credit carryforwards have no expiration date, respectively. The domestic federal foreign tax credits are partially offset by a valuation allowance.
In 2012, the Company repatriated $8,953 of cash from its foreign subsidiaries in order to reduce its credit and currency exposure for cash held in foreign currencies or in non-U.S. banks and utilized the excess cash for debt reduction. The Company utilized fully valued domestic tax credits in 2012 to completely offset any tax impact of the foreign income inclusion. Historically, the Company intended to reinvest foreign earnings indefinitely outside of the U.S. and only considered repatriating excess cash from foreign subsidiaries if it could utilize fully valued domestic tax attributes to completely offset any tax expense that would otherwise result. Unrecognized foreign tax credits and fully valued foreign tax credit carryovers had been available to offset any potential U.S. tax liability. Therefore, the Company had not provided U.S. federal or state income taxes or foreign withholding taxes on its undistributed earnings from foreign operations prior to 2012. During the fourth quarter of 2012 the Company completed a detailed forecast of foreign source income by jurisdiction as part of the ongoing process to evaluate its valuation allowance against deferred tax assets. As part of this process, as well as a continuing desire to limit its credit and currency exposure related to cash held in foreign currencies or in non-U.S. banks, the Company determined that it is likely that a portion of the undistributed earnings of its foreign subsidiaries will be repatriated to the U.S. in the future. Accordingly, the Company changed its indefinite reinvestment assertion and has provided a deferred tax liability of $568 on undistributed foreign earnings as of December 31, 2013. Subject to limitations, U.S. income tax on such foreign earnings, when actually repatriated, may be reduced or eliminated by unrecognized foreign tax credits that may be generated in connection with the repatriation, or by existing foreign tax credits or other tax attributes for which a valuation allowance was released in the fourth quarter of 2012. The Company monitors available evidence and management’s plans for foreign earnings and expects to continue to provide deferred tax expense based on the tax liability that would be due upon repatriation of amounts not considered permanently reinvested.
The following table summarizes the activity related to the Company’s unrecognized tax benefits as of December 31, 2013, 2012 and 2011:
		2013			2012			2011
Balance at January 1		$	3,967		$	4,328		$	4,085
Gross increases related to current period tax positions			257			348			317
Gross (decreases)/increases related to prior period tax positions			(427	)		(483	)		95
Expirations of statute of limitations for the assessment of taxes			(37	)		(113	)		(38	)
Settlements			-			(175	)		-
Foreign currency translation			162			62			(131	)
Balance at December 31		$	3,922		$	3,967		$	4,328
Of the total balance of unrecognized tax benefits at December 31, 2013, $3,922, if recognized, would affect the effective tax rate.
Gross interest and penalties at December 31, 2013, 2012 and 2011 of $5,005, $4,511 and $3,427, respectively, related to the above unrecognized tax benefits are not reflected in the table above. In 2013, 2012 and 2011, the Company accrued $219, $985 and $328, respectively, of interest and penalties in the income statement. Consistent with prior periods, the Company recognizes interest and penalties within its income tax provision.
Tax years 2007 and forward in the U.S. are open to examination by the IRS. The Company is also subject to examinations in its non-U.S. jurisdictions for 2008 and later years.
The Company is also subject to audits in various states for various years in which it has filed income tax returns. Previous state audits have resulted in immaterial adjustments. In the majority of states where the Company files, the Company is subject to examination for tax years 2009 and forward.
In 2009, a subsidiary of the Company was examined by a European tax authority, which challenged the business purpose of the deductibility of certain intercompany transactions from 2003 and issued formal assessments against the subsidiary. In 2010, the Company filed to litigate the matter. The first court date, which pertained to the smaller of the assessments, was held in 2011, after which the court issued its ruling in favor of the Company. The tax authorities appealed this ruling and the appeals court again ruled in the Company’s favor in 2012. The first court date for the larger of the assessments was held in September 2012 and the court issued rulings in favor of the Company in June 2013 and December 2013. In 2013, the Company increased its reserve for unrecognized tax benefits for this matter by $450, including $279 of foreign currency translation. Any ruling reached by any of the courts may be subject to further appeals, and as such the final date of resolution of this matter is uncertain at this time. However, within the next twelve months it is possible that factors such as new developments, settlements or judgments may require the Company to increase its reserve for unrecognized tax benefits by up to approximately $8,000 or decrease its reserve by approximately $6,400, including penalties and interest. If the court rules against the Company in subsequent court proceedings, a payment for the amount of the judgment, including any penalties and interest, will be due immediately while the case is appealed. The Company has analyzed these issues in accordance with guidance on uncertain tax positions and believes at this time that its reserves are adequate, and intends to vigorously defend itself.
In the next twelve months, other than as noted above, the Company may increase its reserve for unrecognized tax benefits for intercompany transactions and acquired tax attributes by approximately $500. This could affect the effective tax rate.

Longterm_Debt

Long-term Debt	12 Months Ended
	Dec. 31, 2013
Long-term Debt [Abstract]	'
Long-term Debt	'
	-10	Long‑term Debt
	In November 2011, the Company entered into a $250,000 five-year Syndicated Senior Revolving Credit Facility (“Credit Facility”) which expires in November 2016. The Company pays interest on this Credit Facility at LIBOR plus 1.75% - 2.50% based upon certain financial measurements. The Credit Facility also includes financial covenants regarding interest coverage and leverage ratios. The Company was in compliance with all financial covenants at December 31, 2013. As of December 31, 2013, there was $79,250 outstanding on the Credit Facility. As of December 31, 2012, there was $64,000 outstanding on the Credit Facility. The 2013 and 2012 weighted average interest rate for long-term bank debt was 2.3% and 2.2%, respectively.

Derivatives_and_Hedging_Activi

Derivatives and Hedging Activities	12 Months Ended
	Dec. 31, 2013
Derivatives and Hedging Activities [Abstract]	'
Derivatives and Hedging Activities	'
	-11	Derivatives and Hedging Activities
	The Company operates internationally and is exposed to fluctuations in foreign exchange rates and interest rates in the normal course of business. The Company, from time to time, uses hedging instruments to reduce exposure to market risks resulting from fluctuations in interest rates and foreign exchange rates.
	All financial instruments involve market and credit risks. The Company is exposed to credit losses in the event of non-performance by the counterparties to the contracts. While there can be no assurance, the Company does not anticipate non-performance by these counterparties.
	Foreign Currency Forward Contracts
	The Company periodically enters into foreign currency forward contracts associated with foreign currency transaction exposures or existing balance sheet exposures, as deemed appropriate.
	The Company’s foreign currency forward contracts generally have varying maturities with none exceeding twelve months.
	In 2012 and 2011, foreign currency forward contracts were designated as cash flow hedges and, accordingly, changes in the fair value of these derivatives were not included in earnings but were included in AOCI. Changes in the fair value of the derivative instruments reported in AOCI were recorded into earnings as a component of product revenue or expense, as applicable, when the forecasted transaction occurred. The ineffective portion of all hedges was recognized in earnings and was immaterial to the Company's financial results.
	There were no foreign currency forward contracts outstanding at December 31, 2013 and 2012.
	Interest Rate Swap
	The Company entered into an interest rate swap in March 2012 to reduce the impact of changes in interest rates on its floating rate debt. The swap is a contract to exchange floating rate for fixed interest payments periodically over the life of the agreement without the exchange of the underlying notional debt amount.
	The swap contract outstanding at December 31, 2013 has been designated as a cash flow hedge and, accordingly, changes in the fair value of this derivative is not recorded in earnings but are recorded each period in AOCI and reclassified into earnings as interest expense in the same period during which the hedged transaction affects earnings. The ineffective portion of all hedges is recognized in earnings and has been immaterial to the Company's financial results.
	As of December 31, 2013, the interest rate swap had a notional value of $60,000, at a fixed rate of 0.92%, maturing in September 2015. The fair value of this swap is based on quoted market prices and was in a loss position of $616 and $930 at December 31, 2013 and 2012, respectively. This loss is reflected in the Company’s balance sheet under the caption “Accrued expenses and other current liabilities.” The Company did not have any interest rate swaps outstanding at December 31, 2011.
	Assuming current market conditions continue, a loss of $420 is expected to be reclassed out of AOCI into earnings within the next 12 months.
	Refer to Note 12 to the Company’s consolidated financial statements for the summary table containing the fair value of the Company’s financial instruments.

Fair_Value_Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2013
Fair Value Measurements [Abstract]	'
Fair Value Measurements	'
	-12	Fair Value Measurements
	U.S. GAAP establishes a valuation hierarchy for disclosure of the inputs to the valuations used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows: Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation; Level 3 inputs are unobservable inputs based on the Company’s assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.
	The following tables provide the assets and liabilities carried at fair value, measured on a recurring basis, as of December 31, 2013 and 2012:
						Fair Value Measurements at December 31, 2013 using:
	Description		Total			(Level 1)		(Level 2)			(Level 3)
	Interest rate swap, liabilities		$	(616	)	$	-	$	(616	)	$	-
	Total		$	(616	)	$	-	$	(616	)	$	-
						Fair Value Measurements at December 31, 2012 using:
	Description		Total			(Level 1)		(Level 2)			(Level 3)
	Interest rate swap, liabilities		$	(930	)	$	-	$	(930	)	$	-
	Total		$	(930	)	$	-	$	(930	)	$	-
	The fair value of the interest rate swap is estimated based on the present value of the difference between expected cash flows calculated at the contracted interest rate and the expected cash flows at current market interest rates using observable benchmarks for the LIBOR forward rates at the end of the period.
	The Company’s financial instruments also include cash and cash equivalents, accounts receivables and accounts payable. The carrying amount of these instruments approximates fair value because of their short-term nature. The carrying amount of the Credit Facility approximates fair value because the debt is based on current rates at which the Company could borrow funds with similar maturities.
	Refer to Note 11 to the Company’s consolidated financial statements for further disclosures on the Company’s financial instruments.

Stockholders_Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2013
Stockholders' Equity [Abstract]	'
Stockholders' Equity	'
	-13	Stockholders' Equity
	The Company has two classes of common shares, Common Stock and Nonvoting Common Stock. Authorized shares of Common Stock were 100,000,000 at December 31, 2013 and 2012. Authorized shares of Nonvoting Common Stock were 730,746 at December 31, 2013 and 2012. Nonvoting Common Stock with a par value of $0.10 has equal rights with Common Stock, with the exception of voting power. Nonvoting Common Stock is convertible, share for share, into Common Stock, subject to any legal requirements applicable to holders restricting the extent to which they may own voting stock. As of December 31, 2013 and 2012, no shares of Nonvoting Common Stock were outstanding. The Company has authorized 5,000,000 shares of Series Preferred Stock, par value $.10, issuable in series and with rights, powers and preferences as may be fixed by the Board of Directors. At December 31, 2013 and 2012, there was no preferred stock outstanding.
	The Company held treasury shares of 1,757,530 and 1,795,082 at December 31, 2013 and 2012, respectively, which are primarily used for issuance to employee compensation plans.
	At December 31, 2013 there were 1,251,625 authorized shares of Common Stock reserved for issuance through equity compensation plans.

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Income/(Loss)	12 Months Ended
	Dec. 31, 2013
Accumulated Other Comprehensive Income/(Loss) [Abstract]	'
Accumulated Other Comprehensive Income/(Loss)	'
	-14	Accumulated Other Comprehensive Income/(Loss)
	The following table provides the changes in AOCI by component, net of tax, for the year ended December 31, 2013:
			Foreign Currency Translation Adjustments				Interest Rate Swap			Pension Plans			Total
	Balance as of December 31, 2012		$	5,177			$	(600	)	$	(38,668	)	$	(34,091	)
	Other comprehensive income/(loss) before reclassifications			4,813				(85	)		9,173			13,901
	Amounts reclassified from accumulated other comprehensive loss			-				289			939			1,228
	Net current-period other comprehensive income			4,813				204			10,112			15,129
	Balance as of December 31, 2013		$	9,990			$	(396	)	$	(28,556	)	$	(18,962	)
	The following table provides the reclassifications out of AOCI by component for the year ended December 31, 2013:
	Details about AOCI Components		Amount Reclassified from AOCI for the year ended December 31, 2013			Affected Line Item in the Consolidated Income Statement
	Losses on cash flow hedge:
	Interest rate swap		$	(444	)	Interest expense, net
			$	155		Tax benefit
			$	(289	)	Net of tax
	Amortization of defined benefit pension items:
	Actuarial losses		$	(1,223	)	Selling, general and administrative expenses
	Actuarial losses			(116	)	Cost of goods sold
	Prior service costs			(50	)	Selling, general and administrative expenses
				(1,389	)	Total before tax
				450		Tax benefit
			$	(939	)	Net of tax
	Total reclassification for the period		$	(1,228	)

Stock_Based_Compensation

Stock Based Compensation	12 Months Ended
	Dec. 31, 2013
Stock Based Compensation [Abstract]	'
Stock Based Compensation	'
	15)	Stock Based Compensation
	The Company recognizes compensation costs for stock options awarded to employees based on their grant-date fair value. The value of each stock option is estimated on the date of grant using the Black-Scholes option-pricing model. The weighted-average fair value per share for the stock options granted to employees for the years ended December 31, 2013, 2012 and 2011 were $7.97, $7.14 and $3.18, respectively.
	The following assumptions were used in determining the fair value of stock options for grants issued in 2013, 2012 and 2011:
			2013			2012			2011
	Expected volatility			44.17%-71.58	%		71.84	%		68.91%-71.53	%
	Expected term		1.25-4.75 years			4.75 years			4.75 years
	Risk-free interest rate			0.12%-1.37	%		0.66	%		1.02%-2.00	%
	The Company does not have any publicly traded stock options; therefore, expected volatilities are based on historical volatility of the Company’s stock. The risk-free interest rate is based on the yield of a zero-coupon U.S. Treasury bond whose maturity period approximates the option’s expected term. The expected term was utilized based on the “simplified” method for determining the expected term of stock options.
	For 2013, 2012, and 2011, the Company recorded $1,994, $1,303 and $1,028, respectively, in selling, general and administrative expenses for stock options. As of December 31, 2013, the total compensation cost related to unvested stock option awards granted to employees but not yet recognized was $6,436. The cost will be amortized on a straight-line basis over the remaining weighted-average vesting period of 2.8 years.
	Cambrex senior executives, through 2009, participated in an executive incentive plan which rewarded achievement with restricted stock units. Members of the Cambrex Board of Directors currently participate in an incentive plan which rewards service with restricted stock units. Awards are made annually and vest over six months. On the six month anniversary of the grant, restrictions on sale or transfer are removed and shares are issued to the Directors. These awards are classified as equity awards.
	For 2013, 2012, and 2011, the Company recorded $427, $446, and $497, respectively, in selling, general and administrative expenses for restricted stock units. As of December 31, 2013, all restricted stock unit grants were fully vested.
	The Company granted equity-settled performance shares (“PSs”) to certain executives. PS awards provide the recipient the right to receive a certain number of shares of the Company’s common stock in the future, which depends on the Company’s level of achievement of revenue and EBITDA growth as compared to the revenue and EBITDA growth of the members of a specified peer group of companies over a three year period. The peer group consists of publicly-traded life sciences companies competing in the same industry as the Company. For 2013, 2012 and 2011, the Company recorded $404, $53 and $40, respectively, in selling, general and administrative expense related to these PS awards.
	The Company granted cash-settled performance share units (“PSUs”) to certain executives. PSU awards provide the recipient the right to receive the cash value of a certain number of shares of the Company’s common stock in the future, which depends on the Company’s level of achievement of revenue and EBITDA growth as compared to the revenue and EBITDA growth of the members of a specified peer group of companies typically over a three year period. The peer group consists of publicly-traded life sciences companies competing in the same industry as the Company. For 2013, 2012 and 2011, the Company recorded $2,620, $1,529 and $415, respectively, in selling, general and administrative expenses for PSU awards. The increase is primarily the result of the Company’s performance compared to the peer group and the Company’s higher share price.
	The following table is a summary of the Company’s stock option activity issued to employees and related information:
						Weighted Average
			Number of Shares			Exercise Price			Options Exercisable
	Outstanding at December 31, 2012			2,264,399			7.02			1,234,623
	Granted			530,835			16.06
	Exercised			(536,565	)		6.01
	Forfeited or expired			(28,700	)		8.99
	Outstanding at December 31, 2013			2,229,969			9.39
	Exercisable at December 31, 2013			1,149,069		$	6.88
	The aggregate intrinsic value for all stock options exercised for the years ended December 31, 2013, 2012 and 2011 was $5,017, $1,658 and $70, respectively. The aggregate intrinsic values for all stock options outstanding and exercisable as of December 31, 2013 were $18,827 and $12,585, respectively.
	A summary of the Company’s nonvested stock options and restricted stock activity is presented below:
			Nonvested Stock Options						Nonvested Restricted Stock
			Number of Shares			Weighted-Average Grant-Date Fair Value			Number of Shares			Weighted-Average Grant-Date Fair Value
	Nonvested at December 31, 2012			1,029,776			4.62			31,145			5.76
	Granted			530,835			7.97			31,648			12.64
	Vested during period			(455,211	)		4.05			(62,793	)		9.23
	Forfeited			(24,500	)		4.73			-			-
	Nonvested at December 31, 2013			1,080,900		$	6.5			-		$	-

Retirement_Plans

Retirement Plans	12 Months Ended
	Dec. 31, 2013
Retirement Plans [Abstract]	'
Retirement Plans	'
	-16	Retirement Plans
	Domestic Pension Plan
	The Company maintains a defined-benefit pension plan (“Domestic Pension Plan”) for certain salaried and certain hourly employees. The Company also has a Supplemental Executive Retirement Plan (“SERP”) for key executives. This plan is non-qualified and unfunded. Benefits accruing under both plans were frozen as of August 31, 2007. In July 2008, the Board of Directors of the Company amended the SERP to allow for lump sum payments effective January 1, 2009. The lump sum value as of January 1, 2009 will be paid in 10 equal actuarial equivalent installments through 2018. For the Domestic Pension Plan, the Company's policy is to fund pension costs to the full extent required by the Internal Revenue Code.
	International Pension Plans
	A foreign subsidiary of the Company maintains a pension plan (“International Pension Plan”) for its employees that conforms to the common practice in that country. Based on local laws and customs, this plan is unfunded.
	Savings Plan
	Cambrex makes available to all domestic employees a savings plan. Employee contributions are matched in part by Cambrex. The cost of this plan amounted to $731, $733 and $604 in 2013, 2012 and 2011, respectively.
	Other
	The Company has a non-qualified Deferred Compensation Plan for Key Executives (“The Plan”). Under this Plan, officers and key employees may elect to defer all or any portion of their pre-tax earnings or elect to defer receipt of the Company’s stock which would otherwise have been issued upon the exercise of the Company’s options. Included within other liabilities at December 31, 2013 and 2012 is $1,049 and $1,118, respectively, representing the Company’s obligation under the plan. The Company invests in certain mutual funds and as such, included within other assets at December 31, 2013 and 2012 is $1,049 and $1,118, respectively, representing the fair value of these funds. The fair values of these mutual funds are based on quoted market prices in active markets (Level 1). The number of Cambrex shares held in trust under this plan as of December 31, 2013 and 2012 were 49,121, and are included as a reduction of equity. The value of the shares held in trust and the corresponding liability of $876 and $559 at December 31, 2013 and 2012, respectively, have also been recorded in equity. The Plan is not funded by the Company, but the Company has established a Deferred Compensation Trust Fund which holds the shares issued. Effective December 2011 the Board of Directors suspended employee contributions to this Plan.
	The benefit obligations as of December 31, 2013 and 2012 are as follows:
			Pension Plans
			Domestic						SERP						International
			2013			2012			2013			2012			2013			2012
	Change in benefit obligation
	Benefit obligation, beginning of year		$	79,958		$	75,430		$	3,690		$	4,153		$	27,033		$	23,020
	Service cost			-			-			-			-			743			660
	Interest cost			3,057			3,284			41			85			658			795
	Actuarial (gain)/loss			(8,269	)		4,699			(9	)		88			(2,314	)		1,852
	Benefits paid			(4,037	)		(3,455	)		(636	)		(636	)		(808	)		(755	)
	Currency translation affect			-			-			-			-			315			1,461
	Benefit obligation, end of year		$	70,709		$	79,958		$	3,086		$	3,690		$	25,627		$	27,033
	The plan assets and funded status of the Domestic Pension Plan as of December 31, 2013 and 2012 are as follows:
			2013			2012
	Change in plan assets
	Fair value of plan assets, beginning of period		$	53,900		$	49,104
	Actual return on plan assets			6,894			5,945
	Contributions			986			2,306
	Benefits paid			(4,037	)		(3,455	)
	Fair value of plan assets, end of period		$	57,743		$	53,900
	Unfunded status			(12,966	)		(26,058	)
	Accrued benefit cost, end of period		$	(12,966	)	$	(26,058	)
	The unfunded status of the SERP was ($3,086) and ($3,690) as of December 31, 2013 and 2012, respectively. The unfunded status of the International Pension Plan was ($25,627) and ($27,033) as of December 31, 2013 and 2012, respectively.
	The amounts recognized in AOCI as of December 31, 2013 and 2012 consist of the following:
			Pension Plans
			Domestic						SERP						International
			2013			2012			2013			2012			2013			2012
	Actuarial loss		$	20,373		$	32,646		$	830		$	958		$	4,765		$	7,354
	Prior service cost/(benefit)			-			-			230			287			(24	)		(31	)
	Total		$	20,373		$	32,646		$	1,060		$	1,245		$	4,741		$	7,323
	The components of net periodic benefit cost are as follows:
			Pension Plans
			Domestic									SERP									International
			2013			2012			2011			2013			2012			2011			2013			2012			2011
	Components of net periodic benefit cost
	Service cost		$	-		$	-		$	-		$	-		$	-		$	-		$	743		$	660		$	611
	Interest cost			3,057			3,284			3,462			41			85			150			658			795			944
	Expected return on plan assets			(3,826	)		(3,674	)		(3,787	)		-			-			-			-			-			-
	Amortization of prior service cost/(benefit)			-			60			436			57			57			57			(7	)		(7	)		(7	)
	Recognized actuarial loss			937			864			458			118			76			49			284			200			111
	Net periodic benefit cost		$	168		$	534		$	569		$	216		$	218		$	256		$	1,678		$	1,648		$	1,659
	The estimated amounts that will be amortized from AOCI into net periodic benefit cost in 2014 are as follows:
			Pension Plans
			Domestic			SERP			International
	Actuarial loss		$	522		$	131		$	160
	Prior service cost/(benefit)			-			57			(7	)
	Total		$	522		$	188		$	153
	Major assumptions used in determining the benefit obligations are presented in the following table:
			2013			2012
	Discount rate:
	Domestic Pension Plan			4.8	%		3.9	%
	SERP			1.4	%		1.35	%
	International Pension Plan			3.7	%		3.4	%
	Rate of compensation increase:
International Pension Plan			2.5	%		2.4	%
Major assumptions used in determining the net benefit cost are presented in the following table:
		2013			2012			2011
Discount rate:
Domestic Pension Plan			3.9	%		4.45	%		5.35	%
SERP			1.35	%		2.4	%		3.4	%
International Pension Plan			3.4	%		3.4	%		4.4	%
Expected return on plan assets:
Domestic Pension Plan			7.25	%		7.5	%		7.5	%
Rate of compensation increase:
International Pension Plan			2.5	%		2.4	%		2.8	%
In making its assumption for the long-term rate of return on plan assets, the Company has utilized historical rates earned on securities allocated consistently with its investments. The discount rate was selected by projecting cash flows associated with plan obligations, which were matched to a yield curve of high quality corporate bonds. The Company then selected the single rate that produced the same present value as if each cash flow were discounted by the corresponding spot rate on the yield curve.
The aggregate Accumulated Benefit Obligation (“ABO”) of $70,709 exceeds plan assets by $12,966 as of December 31, 2013 for the Domestic Pension Plan. The aggregate ABO is $24,243 for the International Pension Plan as of December 31, 2013. The International Pension Plan is unfunded.
The Company expects to contribute approximately $2,700 in cash to the Domestic Pension Plan in 2014. The Company does not expect to contribute cash to its International Pension Plan in 2014.
The following benefit payments are expected to be paid out of the plans:
		Pension Plans
		Domestic			SERP			International
2014		$	3,527		$	731		$	824
2015		$	3,478		$	609		$	836
2016		$	3,486		$	609		$	837
2017		$	3,628		$	609		$	858
2018		$	3,654		$	609		$	934
2019-2023		$	21,028			-		$	5,681
The investment objective for the Domestic Pension Plan’s assets is to achieve long-term growth with exposure to risk at an appropriate level. The Company invests in a diversified asset mix consisting of equities (domestic and international) and taxable fixed income securities. Assets are managed to obtain the highest total rate of return in keeping with a moderate level of risk. The target allocations for plan assets are 30% - 80% equity securities, 25% - 45% U.S. fixed income and 0% - 10% all other investments. Equity securities primarily include investments in large-cap and small-cap companies, U.S. Fixed income securities include high quality corporate bonds and U.S. government securities. Other types of investments include real asset funds, consisting primarily of investments in commodities, and Treasury Inflation-Protected Securities (“TIPS”).
The fair values of the Company’s pension plan assets by asset category are as follows:
					Fair Value Measurements at December 31, 2013 using:
Asset Category		Total			(Level 1)			(Level 2)			(Level 3)
Equity securities:
U.S. companies		$	20,633		$	-		$	20,633		$	-
International companies			11,157			-			11,157			-
U.S. fixed income			18,736			-			16,660			2,076
Commodities			4,436			-			4,436			-
TIPS			2,781			-			2,781			-
		$	57,743		$	-		$	55,667		$	2,076
					Fair Value Measurements at December 31, 2012 using:
Asset Category		Total			(Level 1)			(Level 2)			(Level 3)
Equity securities:
U.S. companies		$	19,238		$	-		$	19,238		$	-
International companies			10,337			-			10,337			-
U.S. fixed income			17,625			-			15,465			2,160
Commodities			4,131			-			4,131			-
TIPS			2,569			-			2,569			-
		$	53,900		$	-		$	51,740		$	2,160
The following table sets forth a summary of the changes in the fair value of the Domestic Plan’s Level 3 assets, which are annuity contracts with an insurance company, for the year ended December 31, 2013:
		Group Annuity Contract
Balance at December 31, 2012		$	2,160
Net investment loss			(84	)
Balance at December 31, 2013		$	2,076

Foreign_Operations_and_Sales

Foreign Operations and Sales	12 Months Ended
	Dec. 31, 2013
Foreign Operations and Sales [Abstract]	'
Foreign Operations and Sales	'
	-17	Foreign Operations and Sales
	The following summarized data represents the gross sales and long lived assets for the Company’s domestic and foreign entities for 2013, 2012 and 2011:
			Domestic		Foreign		Total
	2013
	Gross sales		$	153,202	$	164,010	$	317,212
	Long-lived assets			59,496		155,151		214,647
	2012
	Gross sales		$	109,729	$	168,202	$	277,931
	Long-lived assets			44,085		149,133		193,218
	2011
	Gross sales		$	83,407	$	171,068	$	254,475
	Long-lived assets			34,885		145,735		180,620
	Export sales, included in domestic gross sales, in 2013, 2012 and 2011 amounted to $86,850, $32,872, and $31,605, respectively.
	Sales to geographic area consist of the following:
			2013		2012		2011
	Europe		$	210,463	$	150,678	$	156,814
	North America			86,974		105,439		75,979
	Asia			13,800		12,827		10,448
	Other			5,975		8,987		11,234
	Total		$	317,212	$	277,931	$	254,475
	One customer accounted for 18.3% of consolidated 2013 gross sales.

Commitments

Commitments	12 Months Ended
	Dec. 31, 2013
Commitments [Abstract]	'
Commitments	'
	-18	Commitments
	The Company has operating leases expiring on various dates through the year 2019. The leases are primarily for the rental of office space, office and laboratory equipment and vehicles. At December 31, 2013, future minimum commitments under non-cancelable operating lease arrangements were as follows:
	Year ended December 31:
	2014		$	968
	2015			830
	2016			539
	2017			515
	2018			442
	2019 and thereafter			101
	Total commitments		$	3,395
	Total operating lease expense was $1,090, $815 and $644 for the years ended December 31, 2013, 2012 and 2011, respectively.
	The Company is party to several unconditional purchase obligations resulting from contracts that contain legally binding provisions with respect to quantities, pricing and timing of purchases. The Company’s purchase obligations mainly include commitments to purchase utilities. At December 31, 2013, future commitments under these obligations were as follows:
	Year ended December 31:
	2014		$	2,171
	2015			598
	2016			-
	2017			-
	2018			-
	Total commitments		$	2,769

Contingencies

Contingencies	12 Months Ended
	Dec. 31, 2013
Loss Contingency Information About Litigation Matters [Abstract]	'
Contingencies	'
	-19	Contingencies
	The Company is subject to various investigations, claims and legal proceedings covering a wide range of matters that arise in the ordinary course of its business activities. The Company continually assesses all known facts and circumstances as they pertain to all legal and environmental matters and evaluates the need for reserves and disclosures as deemed necessary based on these facts and circumstances. These matters, either individually or in the aggregate, could result in actual costs that are significantly higher than the Company’s current assessment and could have a material adverse effect on the Company's operating results and cash flows in future reporting periods. While these matters could have a material adverse effect on the Company’s financial condition, based upon past experience, it is likely that payments significantly in excess of current reserves, if required, would be made over an extended number of years.
	Environmental
	In connection with laws and regulations pertaining to the protection of the environment, the Company and its subsidiaries are a party to several environmental proceedings and remediation activities and along with other companies, have been named a potentially responsible party (“PRP”) for certain waste disposal sites ("Superfund sites"). Substantially all of the liabilities currently recorded on the Company’s balance sheet for environmental proceedings are associated with discontinued operations.
	It is the Company’s policy to record appropriate liabilities for environmental matters where remedial efforts are probable and the costs can be reasonably estimated. Such liabilities are based on the Company’s best estimate of the undiscounted future costs required to complete the remedial work. Each of these matters is subject to various uncertainties, and it is possible that some of these matters will be decided unfavorably against the Company. The resolution of such matters often spans several years and frequently involves regulatory oversight or adjudication. Additionally, many remediation requirements are fluid and are likely to be affected by future technological, site and regulatory developments. Consequently, the ultimate liability with respect to such matters, as well as the timing of cash disbursements cannot be determined with certainty.
	In matters where the Company has been able to reasonably estimate its liability, the Company has accrued for the estimated costs associated with the study and/or remediation of applicable sites. These reserves were $10,881 and $5,096 at December 31, 2013 and 2012, respectively. The increase in the reserve includes adjustments to reserves of $7,434 and the impact of currency translation of $21 partially offset by payments of $1,670. The reserves are adjusted periodically as remediation efforts progress or as additional technical, regulatory or legal information becomes available. Based upon available information and analysis, the Company's current reserve represents management's best estimate of the probable and estimable costs associated with environmental proceedings. Given the uncertainties regarding the outcome of investigative and study activities, the status of laws, regulations, enforcement, policies, the impact of other PRPs, technology and information related to individual sites, the Company does not believe it is possible to currently develop an estimate of the range of reasonably possible environmental loss in excess of its reserves.
	CasChem
	As a result of the sale of the Bayonne, New Jersey facility, the Company became obligated to investigate site conditions and conduct required remediation under the New Jersey Industrial Site Recovery Act. The Company intends to continue implementing a sampling plan at the property pursuant to the New Jersey Department of Environmental Protection’s (“NJDEP”) private oversight program. The results of the completed sampling, and any additional sampling deemed necessary, will be used to develop an estimate of the Company's future liability for remediation costs. As of December 31, 2013, the Company’s reserve was $249.
	Cosan
	The Company is currently implementing a sampling and pilot program at its Cosan Clifton, New Jersey site pursuant to the NJDEP private oversight program. The results of the sampling and pilot program to date have been used to develop an estimate of the Company's future liability for remediation costs. As of December 31, 2013, the Company’s reserve was $1,259.
	Additionally, the Company is currently implementing a sampling and pilot program at its Cosan Carlstadt, New Jersey site pursuant to the NJDEP private oversight program. The results of the sampling and pilot program to date have been used to develop an estimate of the Company's future liability for remediation costs. As of December 31, 2013, the Company’s reserve was $1,136.
	Berry’s Creek
	The Company received a notice from the United States Environmental Protection Agency (“USEPA”) that two former subsidiaries of the Company are considered PRPs at the Berry’s Creek Study Area in New Jersey. These subsidiaries are among many other PRPs that were listed in the notice. Pursuant to the notice, the PRPs have been asked to perform a remedial investigation and feasibility study of the Berry’s Creek site. The Company has joined the group of PRPs and entered into an Administrative Settlement Agreement (“Agreement”) and Order on Consent with the USEPA agreeing to jointly conduct or fund an appropriate remedial investigation and feasibility study of the Berry’s Creek site with the other PRPs in the Agreement. The PRPs have engaged consultants to perform the work specified in the Agreement and develop a method to allocate related costs among the PRPs. As of December 31, 2013, the Company’s reserve was $249 to cover the current phase of investigation based on a tentative agreement on the allocation of the site investigation costs among the PRPs. The investigation is ongoing and at this time it is too early to predict the extent of additional liabilities.
	Maybrook Site
	A subsidiary of Cambrex is named a PRP of a former production facility in Hamptonburgh, New York by the USEPA in connection with the discharge, under appropriate permits, of wastewater at that site prior to Cambrex's acquisition of this facility in 1986. The PRPs implemented soil remediation which was completed in 2012 pending approval by the USEPA. The PRPs will continue implementing the ground water remediation at the site. As of December 31, 2013, the Company’s reserve was $322 to cover remaining ground water remediation and long-term monitoring.
	Harriman Site
	Subsidiaries of Cambrex and Pfizer are named as responsible parties for the Company’s former Harriman, New York production facility by the New York State Department of Environmental Conservation (“NYSDEC”). A final ROD describing the Harriman site remediation responsibilities for Pfizer and the Company was issued in 1997 (the "1997 ROD") and incorporated into a federal court Consent Decree in 1998 (the “Consent Decree”). Site clean-up work under the 1997 ROD is on-going and is being jointly performed by Pfizer and the Company, with NYSDEC oversight. ELT Harriman, LLC ("ELT"), the current owner of the Harriman site, conducted other investigation and remediation activities under a separate NYSDEC directive.
	In October 2013, the NYSDEC sent the Company, Pfizer, ELT and the immediately preceding owner Vertellus Specialties Holdings (“Vertellus”) an enforcement letter demanding that the Company and Pfizer submit a work plan for the further study and remediation of certain areas of the Harriman site, including the evaluation of certain remedies that the Company has contended are not required by the 1997 ROD. In December 2013, the Company, Pfizer and the NYSDEC entered into a federal court stipulation withdrawing the October 2013 enforcement letter as to the Company and Pfizer, and resolving certain disputes about the scope of their obligations under the Consent Decree and the 1997 ROD. Pursuant to the stipulation, the Company and Pfizer are required to carry out an environmental investigation and study of certain areas of the Harriman Site.
	No final remedy for the site has been determined, which will follow further investigation and discussions with the NYSDEC. The Company estimated the range for its share of the liability at the site to be between $2,000 and $7,000. As of December 31, 2013, the Company’s reserve was $3,690, which reflects amounts for work which the Company currently considers to be probable and estimable. At this time, the Company is unable to provide an estimate of the ultimate investigative and remedial costs to the Company for any final remedy selected by NYSDEC.
	The Company intends to enforce all of its contractual rights to recover costs and for indemnification, and has filed such claims in an arbitration proceeding against ELT and Vertellus. ELT has filed counterclaims for contractual indemnification. Currently, the arbitration proceeding is stayed indefinitely.
	Scientific Chemical Processing (“SCP”) Superfund Site
	A subsidiary of Cambrex was named a PRP of the SCP Superfund site, located in Carlstadt, New Jersey, in the early 1980’s along with approximately 130 other PRPs. The site is a former waste processing facility that accepted various waste for recovery and disposal including processing wastewater from this subsidiary. The PRPs are in the process of implementing a final remedy at the site. The SCP Superfund site has also been identified as a PRP in the Berry’s Creek Superfund site (see previous discussion). For over a decade, the remediation has been funded by de minimus settlements and by the insurers of the SCP Superfund site’s owners and operators. However, due to an unexpected increase in remediation costs at the site and costs to related to SCP’s involvement in the Berry’s Creek investigation, the PRP group approved the assessment of an additional cash contribution by the PRP group. While the Company continues to dispute the methodology used by the PRP group to arrive at its allocation for the cash contribution, the Company has paid the recent funding requests. A final allocation of SCP Site costs is expected to be developed during 2014. As of December 31, 2013, the Company’s reserve was $1,250 of which approximately $735 is expected to be covered by insurance.
	Newark Bay Complex Litigation
	CasChem and Cosan have been named as two of several hundred third-party defendants in a third-party complaint filed in February 2009, by Maxus Energy Corporation (“Maxus”) and Tierra Solutions, Inc. (“Tierra”). The original plaintiffs include the NJDEP, the Commissioner of the NJDEP and the Administrator of the New Jersey Spill Compensation Fund, which originally filed suit in 2005 against Maxus, Tierra and other defendants seeking recovery of cleanup and removal costs for alleged discharges of dioxin and other hazardous substances into the Passaic River, Newark Bay, Hackensack River, Arthur Kill, Kill Van Kull and adjacent waters (the “Newark Bay Complex”). Maxus and Tierra are now seeking contributions from third-party defendants, including subsidiaries of the Company, for cleanup and removal costs for which each may be held liable in the primary lawsuit. Maxus and Tierra also seek recovery for cleanup and removal costs that each has incurred or will incur relating to the Newark Bay Complex. The Company has entered into a settlement agreement with the original plaintiffs, which has been approved by the Court. The settlement resolves the lawsuit and provides the Company with some protections from certain claims. The settlement resolves any claims that the original plaintiffs have against the Company and will require Maxus and Tierra to re-file their claims against the Company in federal court. As of December 31, 2013, the Company’s reserve is $324 for this matter.
	The Company is involved in other environmental matters where the range of liability is not reasonably estimable at this time and it is not foreseeable when information will become available to provide a basis for adjusting or recording a reserve, should a reserve ultimately be required.
	Litigation and Other Matters
	Lorazepam and Clorazepate
	In 1998, the Company and a subsidiary were named as defendants along with Mylan Laboratories, Inc. (“Mylan”) and Gyma Laboratories, Inc. (“Gyma”) in a proceeding instituted by the Federal Trade Commission in the United States District Court for the District of Columbia (the “District Court”). Suits were also commenced by several State Attorneys General and class action complaints by private plaintiffs in various state courts. The suits alleged violations of the Federal Trade Commission Act arising from exclusive license agreements between the Company and Mylan covering two APIs (Lorazepam and Clorazepate).
	All cases have been resolved except for one brought by four health care insurers. In the remaining case, the District Court entered judgment after trial in 2008 against Mylan, Gyma and Cambrex in the total amount of $19,200, payable jointly and severally, and also a punitive damage award against each defendant in the amount of $16,709. In addition, at the time, the District Court ruled that the defendants were subject to a total of approximately $7,500 in prejudgment interest. The case is currently pending before the District Court following a January 2011 remand by the Court of Appeals where briefing related to whether the court has jurisdiction over certain self-funded customer plaintiffs has been completed and the parties are currently waiting for a ruling by the court.
	In 2003, Cambrex paid $12,415 to Mylan in exchange for a release and full indemnity against future costs or liabilities in related litigation brought by the purchasers of Lorazepam and Clorazepate, as well as potential future claims related to the ongoing matter. Mylan has submitted a surety bond underwritten by a third-party insurance company in the amount of $66,632. In the event of a final settlement or final judgment, Cambrex expects any payment required by the Company to be made by Mylan under the indemnity described above.
	Other
	The Company has commitments incident to the ordinary course of business including corporate guarantees of certain subsidiary obligations to the Company’s lenders related to financial assurance obligations under certain environmental laws for remediation; closure and third party liability requirements of certain of its subsidiaries and a former operating location; contract provisions for indemnification protecting its customers and suppliers against third party liability for the manufacture and sale of Company products that fail to meet product warranties and contract provisions for indemnification protecting licensees against intellectual property infringement related to licensed Company technology or processes.
	Additionally, as permitted under Delaware law, the Company indemnifies its officers, directors and employees for certain events or occurrences while the officer, director or employee is, or was, serving at the Company’s request in such capacity. The term of the indemnification period is for the officer's, director's or employee’s lifetime. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has a director and officer insurance policy that covers a portion of any potential exposure. The Company currently believes the estimated fair value of its indemnification agreements is not material based on currently available information, and as such, the Company had no liabilities recorded for these agreements as of December 31, 2013.
	Cambrex's subsidiaries are party to a number of other proceedings that are not considered material at this time.

Discontinued_Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2013
Discontinued Operations [Abstract]	'
Discontinued Operations	'
	-20	Discontinued Operations
	For 2013, the Company recorded pre-tax charges of $6,708, reduced by a tax benefit of $2,348, for environmental remediation related to sites of divested businesses as discontinued operations. For 2012, the Company recorded pre-tax charges of $1,425, reduced by a tax benefit of $499, for environmental remediation related to sites of divested businesses as discontinued operations. For 2011, the Company recorded pre-tax charges of $2,851 for environmental remediation, net of insurance proceeds, related to sites of divested businesses as discontinued operations.

Gain_on_Sale_of_Asset

Gain on Sale of Asset	12 Months Ended
	Dec. 31, 2013
Gain on Sale of Asset [Abstract]	'
Gain on Sale of Asset	'
	-21	Gain on Sale of Asset
	For the year ended December 31, 2013, the Company recorded a gain on the sale of an office building of $4,680. The carrying value of the building was not material. The Company received cash of approximately $1,900 and a secured note of approximately $3,200 as of December 31, 2013.

SELECTED_QUARTERLY_FINANCIAL_A

SELECTED QUARTERLY FINANCIAL AND SUPPLEMENTARY DATA - UNAUDITED	12 Months Ended
	Dec. 31, 2013
SELECTED QUARTERLY FINANCIAL AND SUPPLEMENTARY DATA - UNAUDITED [Abstract]	'
Selected Quarterly Financial and Supplementary Data	'
	CAMBREX CORPORATION AND SUBSIDIARIES
	SELECTED QUARTERLY FINANCIAL AND SUPPLEMENTARY DATA - UNAUDITED
	(in thousands, except share and per share data)
			1st			2nd			3rd			4th
			Quarter (1)			Quarter			Quarter			Quarter
	2013
	Gross sales		$	74,581		$	61,628		$	77,992		$	103,011
	Net revenues			74,885			62,803			77,452			103,036
	Gross profit			24,749			19,251			24,966			33,938
	Income from continuing operations			11,425			3,136			6,274			9,440
	Loss from discontinued operations (3)			(257	)		(862	)		(2,700	)		(541	)
	Net income			11,168			2,274			3,574			8,899
	Earnings per share of common stock: (4)
	Basic			0.37			0.07			0.12			0.29
	Diluted			0.36			0.07			0.12			0.29
	Average shares:
	Basic			29,970			30,089			30,184			30,353
	Diluted			30,788			30,956			31,052			31,166
			1st			2nd			3rd			4th
			Quarter			Quarter			Quarter			Quarter (2)
	2012
	Gross sales		$	70,559		$	77,142		$	59,841		$	70,389
	Net revenues			70,228			77,133			59,210			69,930
	Gross profit			22,428			28,445			18,531			21,083
	Income from continuing operations			7,038			9,928			2,021			44,242
	Loss from discontinued operations (3)			-			-			(332	)		(594	)
	Net income			7,038			9,928			1,689			43,648
	Earnings per share of common stock: (4)
	Basic			0.24			0.34			0.06			1.46
	Diluted			0.24			0.33			0.06			1.42
	Average shares:
	Basic			29,602			29,623			29,711			29,874
	Diluted			29,886			29,912			30,587			30,717
	-1	Income from continuing operations includes a gain on sale of an office building of $4,680 and a corresponding tax expense of $1,470 and a benefit of $1,155 due to changes in tax laws.
	-2	Income from continuing operations includes the reversal of a valuation allowance on deferred tax assets of $36,287 and the impact on deferred taxes of a statutory rate change of $1,328.
	-3	Discontinued operations include charges for environmental remediation related to sites of divested businesses.
	-4	Earnings per share calculations for each of the quarters are based on the weighted average number of shares outstanding for each period. As such, the sum of the quarters may not necessarily equal the earnings per share amount for the year.

SCHEDULE_II_VALUATION_AND_QUAL

SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
	Dec. 31, 2013
SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS [Abstract]	'
SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS	'
	CAMBREX CORPORATION
	VALUATION AND QUALIFYING ACCOUNTS
	FOR THE YEARS ENDED DECEMBER 31, 2013, 2012 and 2011
	(dollars in thousands)
	Column A	Column B		Column C						Column D		Column E
				Additions
		Balance Beginning of Year		Charged/ (Credited) to Cost and Expenses			Charged/ (Credited) to Other Accounts			Deductions		Balance End of Year
	Description
	Year ended December 31, 2013:
	Doubtful trade receivables and returns and allowances	$	652	$	433		$	27		$	54	$	1,058
	Deferred tax valuation allowance		29,941		(97	)		46			-		29,890
	Year ended December 31, 2012:
	Doubtful trade receivables and returns and allowances	$	450	$	193		$	12		$	3	$	652
	Deferred tax valuation allowance		77,571		(45,105	)		(2,525	)		-		29,941
	Year ended December 31, 2011:
	Doubtful trade receivables and returns and allowances	$	1,083	$	(103	)	$	(39	)	$	491	$	450
	Deferred tax valuation allowance		77,849		(9,546	)		9,268			-		77,571

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]	'
Principles of Consolidation	'
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Equity investments in which the Company exercises significant influence but does not control, are accounted for using the equity method. The Company’s share of its equity method investees’ earnings or losses are included in “Other expenses/(income)” in the income statements. The Company eliminates its pro rata share of gross profit on sales with its equity method investees for assets still remaining in inventory at the end of the reporting period. All other significant intercompany balances and transactions have been eliminated in consolidation.
Cash Equivalents	'
	Cash Equivalents
	Temporary cash investments with an original maturity of less than three months are considered cash equivalents. The carrying amounts approximate fair value.
Allowance for Doubtful Accounts	'
	Allowance for Doubtful Accounts
	The Company maintains allowances for doubtful accounts relating to estimated losses resulting from customers being unable to make required payments. Allowances for doubtful accounts are based on historical experience and known factors regarding specific customers and the industries in which those customers operate. If the financial condition of the Company’s customers were to deteriorate, resulting in their inability to make payments, additional allowances would be required.
Concentrations of credit risk	'
	Concentrations of credit risk
	Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. In the normal course of business, the Company maintains cash balances with European Union banks ranging from $5,000 - $15,000. The Company routinely monitors the risks associated with these institutions and diversifies its exposure by maintaining smaller balances with multiple financial institutions. Concentrations of credit risk with respect to accounts receivable are limited due to the Company's large number of customers and their dispersion throughout the world.
Derivative Instruments	'
	Derivative Instruments
	Derivative financial instruments are periodically used by the Company primarily for hedging purposes to mitigate a variety of working capital, investment and borrowing risks. The Company primarily uses foreign currency forward contracts to minimize foreign currency exchange rate risk associated with foreign currency transactions. Gains and losses on these hedging transactions are generally recorded in earnings in the same period as they are realized, which is usually the same period as the settlement of the underlying transactions. The Company uses interest rate swap instruments only as hedges. As such, the differential to be paid or received in connection with these instruments is accrued and recognized in income as an adjustment to interest expense.
	The Company formally documents the relationship between hedging instruments and hedged items, as well as its risk management objectives and strategies for undertaking various hedging relationships. All cash flow hedges are linked to transactions and the Company assesses effectiveness at inception and on a quarterly basis. If it is determined that a derivative instrument is not highly effective or the transaction is no longer deemed probable of occurring, the Company discontinues hedge accounting and recognizes the ineffective portion in current period earnings.
Inventories	'
	Inventories
	Inventories are stated at the lower of cost, determined on a first‑in, first‑out basis, or market. The determination of market value involves assessment of numerous factors, including estimated selling prices. Reserves are recorded to reduce the carrying value for inventory determined to be damaged, obsolete or otherwise unsaleable.
Property, Plant and Equipment	'
	Property, Plant and Equipment
	Property, plant and equipment is stated at cost, net of accumulated depreciation. Plant and equipment are depreciated on a straight‑line basis over the estimated useful lives for each applicable asset group as follows:
	Buildings and improvements	20 to 30 years, or term of lease if applicable
	Machinery and equipment	7 to 15 years
	Furniture and fixtures	5 to 7 years
	Computer hardware and software	3 to 7 years
	Expenditures for additions, major renewals or betterments are capitalized and expenditures for maintenance and repairs are charged to income as incurred.
	When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in costs of goods sold or operating expenses. Interest is capitalized in connection with the construction and acquisition of assets that are capitalized over longer periods of time for larger amounts. The capitalized interest is recorded as part of the cost of the asset to which it relates and is amortized over the asset’s estimated useful life. Total interest capitalized in connection with ongoing construction activities was $298 in 2013 and negligible in both 2012 and 2011.
Impairment of Goodwill	'
	Impairment of Goodwill
	The Company reviews the carrying value of goodwill to determine whether impairment may exist on an annual basis or whenever it has reason to believe goodwill may not be recoverable. The annual impairment test of goodwill is performed during the fourth quarter of each fiscal year. The Company did not have an impairment for any of the years presented.
	Goodwill impairment is determined using a two-step process. The first step of the goodwill impairment test is used to identify potential impairment by comparing the fair value of each reporting unit, determined using various valuation techniques, with the primary technique being a discounted cash flow analysis, to its carrying value. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered not impaired and the second step of the impairment test is unnecessary. If the carrying amount of a reporting unit exceeds its fair value, the second step of the goodwill impairment test is performed to measure the amount of impairment loss, if any. The second step of the goodwill impairment test compares the implied fair value of the reporting unit’s goodwill with the carrying amount of that goodwill. If the carrying amount of the reporting unit’s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to that excess.
Impairment of Long-Lived Assets	'
	Impairment of Long-Lived Assets
	The Company assesses the impairment of its long-lived assets, including amortizable intangible assets, and property, plant and equipment, whenever economic events or changes in circumstances indicate that the carrying amounts of the assets may not be recoverable. Long lived assets are considered to be impaired when the sum of the undiscounted expected future operating cash flows is less than the carrying amounts of the related assets. If impaired, the assets are written down to fair market value.
	The Company has investments in partially-owned affiliates. It does not separately test an investee’s underlying assets for impairment but will recognize its share of any impairment charge recorded by an investee in earnings and consider the effect of the impairment on its investment. A series of operating losses of an investee or other factors may indicate that a decrease in value of the investment has occurred that is other than temporary. A loss in value of an investment that is other than a temporary decline would be recognized as an impairment if the fair value of that investment is less than its carrying amount.
Revenue Recognition	'
	Revenue Recognition
	Revenues are generally recognized when title to products and risk of loss are transferred to customers. Additional conditions for recognition of revenue are that collection of sales proceeds is reasonably assured and the Company has no further performance obligations.
	Amounts billed in advance are recorded as deferred revenue on the balance sheet. Since payments received are sometimes non-refundable, the termination of a contract by a customer prior to its completion could result in an immediate recognition of deferred revenue relating to payments already received but not previously recognized as revenue.
	Sales terms to certain customers include rebates if certain conditions are met. Additionally, sales are generally made with a limited right of return under certain conditions. The Company estimates these rebates and returns at the time of sale based on the terms of agreements with customers and historical experience and recognizes revenue net of these estimated costs which are classified as allowances and rebates.
	The Company bills a portion of freight cost incurred on shipments to customers. Amounts billed to customers are recorded within net revenues. Freight costs are reflected in cost of goods sold.
Income Taxes	'
	Income Taxes
	The Company and its eligible subsidiaries file a consolidated U.S. income tax return. Foreign subsidiaries are consolidated for financial reporting but are not eligible to be included in the consolidated U.S. income tax return, however the earnings of foreign subsidiaries are generally taxed by the U.S. when repatriated and such U.S. tax may be reduced or eliminated by federal foreign tax credits based on the foreign income and withholding taxes paid or accrued by the foreign subsidiary. Historically, the Company intended to reinvest foreign earnings indefinitely outside of the U.S. and only considered repatriating excess cash from foreign subsidiaries if it could utilize fully valued domestic tax attributes to completely offset any tax expense that would otherwise result. Unrecognized foreign tax credits and fully valued foreign tax credit carryovers were available to offset any potential U.S. tax liability. Therefore, the Company had not provided U.S. federal income taxes or foreign withholding taxes on its undistributed earnings from foreign operations prior to 2012. During the fourth quarter of 2012 the Company completed a detailed forecast of foreign source income by jurisdiction as part of the ongoing process to evaluate its valuation allowance against deferred tax assets. As part of this process, as well as a continuing desire to limit its credit and currency exposure for cash held in foreign currencies or in non-U.S. banks, the Company determined that it is likely that a portion of the undistributed earnings of its foreign subsidiaries will be repatriated to the U.S. in the future. Accordingly, the Company changed its indefinite reinvestment assertion and has provided a deferred tax liability of $568 on undistributed foreign earnings as of December 31, 2013. Subject to limitations, U.S. income tax on such foreign earnings, when actually repatriated, may be reduced or eliminated by unrecognized foreign tax credits that may be generated in connection with the repatriation, or by existing foreign tax credits or other tax attributes for which valuation allowance was released in the fourth quarter of 2012. The Company monitors available evidence and management’s plans for foreign earnings and expects to continue to provide deferred tax expense based on the tax liability that would be due upon repatriation of amounts not considered permanently reinvested.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Environmental Costs	'
	Environmental Costs
	The Company is subject to extensive and changing federal, state, local and foreign environmental laws and regulations, and has made provisions for the estimated financial impact of environmental activities. The Company’s policy is to accrue environmental related costs of a non-capital nature, including estimated litigation costs, when those costs are believed to be probable and can be reasonably estimated. The quantification of environmental exposures requires an assessment of many factors, including changing laws and regulations, advancements in environmental technologies, the quality of information available related to specific sites, the assessment stage of each site investigation, preliminary findings and the length of time involved in remediation or settlement. Such accruals are adjusted as further information develops or circumstances change. For certain matters, the Company expects to share costs with other parties. Recoveries of environmental remediation costs from other parties are recorded as assets when their receipt is deemed certain.
Foreign Currency	'
	Foreign Currency
	The functional currency of the Company's foreign subsidiaries is the applicable local currency. The translation of the applicable foreign currencies into U.S. dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for revenue and expense accounts and cash flows using average rates of exchange prevailing during the year. Adjustments resulting from the translation of foreign currency financial statements are accumulated in a separate component of stockholders' equity until the entity is sold or substantially liquidated. Gains or losses relating to transactions of a long-term investment nature are accumulated in stockholders' equity. Gains or losses resulting from third-party foreign currency transactions are included in the income statement as a component of other revenues in the consolidated income statement. Foreign currency net transaction losses were $133, $274 and $62 in 2013, 2012 and 2011, respectively.
Earnings per Common Share	'
	Earnings per Common Share
	All diluted earnings per share are computed on the basis of the weighted average shares of common stock outstanding plus common equivalent shares arising from the effect of dilutive stock options, equity-settled performance shares and restricted stock units, using the treasury stock method.
	For the years ended December 31, 2013, 2012 and 2011, shares of 916,350, 580,745, and 1,839,373, respectively, were not included in the calculation of diluted shares outstanding because the effect would be anti-dilutive.
Comprehensive Income/(Loss)	'
	Comprehensive Income/(Loss)
	Included within accumulated other comprehensive income/(loss) for the Company are foreign currency translation adjustments, changes in the fair value related to derivative instruments classified as cash flow hedges, net of related tax, and changes in the pensions, net of tax. Total comprehensive income/(loss) for the years ended December 31, 2013 and 2012 are included in the Statements of Comprehensive Income/(Loss).
	The components of accumulated other comprehensive loss in stockholders’ equity are as follows:
		2013			2012
	Foreign currency translation	$	9,990		$	5,177
	Unrealized loss on hedging contracts, net of tax		(396	)		(600	)
	Pensions, net of tax		(28,556	)		(38,668	)
	Total	$	(18,962	)	$	(34,091	)
Reclassification	'
	Reclassification
	Certain reclassifications have been made to prior year amounts to conform with current year presentation.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]	'
Schedule of estimated useful lives for each asset group	'
	Property, plant and equipment is stated at cost, net of accumulated depreciation. Plant and equipment are depreciated on a straight‑line basis over the estimated useful lives for each applicable asset group as follows:
	Buildings and improvements	20 to 30 years, or term of lease if applicable
	Machinery and equipment	7 to 15 years
	Furniture and fixtures	5 to 7 years
	Computer hardware and software	3 to 7 years
Components of accumulated other comprehensive loss in stockholders' equity	'
	The components of accumulated other comprehensive loss in stockholders’ equity are as follows:
		2013			2012
	Foreign currency translation	$	9,990		$	5,177
	Unrealized loss on hedging contracts, net of tax		(396	)		(600	)
	Pensions, net of tax		(28,556	)		(38,668	)
	Total	$	(18,962	)	$	(34,091	)

Net_Inventories_Tables

Net Inventories (Tables)	12 Months Ended
	Dec. 31, 2013
Net Inventories [Abstract]	'
Net Inventories	'
	Net inventories consist of the following:
		December 31,
		2013		2012
	Finished goods	$	29,797	$	30,262
	Work in process		31,990		23,533
	Raw materials		22,580		12,352
	Supplies		5,598		5,074
	Total	$	89,965	$	71,221

Property_Plant_and_Equipment_T

Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Schedule of property, plant and equipment	'
	Property, plant and equipment consist of the following:
		December 31,
		2013			2012
	Land	$	4,312		$	4,221
	Buildings and improvements		108,460			92,307
	Machinery and equipment		398,490			364,370
	Furniture and fixtures		1,884			1,813
	Construction in progress		16,808			21,382
	Total		529,954			484,093
	Accumulated depreciation		(357,988	)		(332,278	)
	Net	$	171,966		$	151,815

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets [Abstract]	'
Change in carrying amount of goodwill	'
	The changes in the carrying amount of goodwill for the years ended December 31, 2013 and 2012 are as follows:
	Balance as of December 31, 2011	$	36,731
	Translation effect		581
	Balance as of December 31, 2012		37,312
	Translation effect		1,358
	Balance as of December 31, 2013	$	38,670
Summary of acquired amortizable intangible assets	'
	Acquired intangible assets, which are amortized, consist of the following:
				As of December 31, 2013
		Amortization Period				Accumulated Amortization			Net Carrying Amount
				Gross Carrying Amount
	Technology-based intangibles	20 years		$	4,192	$	(786	)	$	3,406
	Customer-related intangibles	10 - 15 years			814		(209	)		605
				$	5,006	$	(995	)	$	4,011
				As of December 31, 2012
		Amortization Period				Accumulated Amortization			Net Carrying Amount
				Gross Carrying Amount
	Technology-based intangibles	20 years		$	4,011	$	(552	)	$	3,459
	Customer-related intangibles	10 - 15 years			778		(146	)		632
				$	4,789	$	(698	)	$	4,091

Accrued_Expense_and_Other_Curr1

Accrued Expense and Other Current Liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Accrued Expenses And Other Current Liabilities [Abstract]	'
Components of accrued expenses and other current liabilities	'
	The components of accrued expenses and other current liabilities are as follows:
		December 31,
		2013		2012
	Salaries and employee benefits payable	$	26,211	$	23,882
	Taxes payable and related reserves		10,168		9,637
	Other		11,719		9,782
	Total	$	48,098	$	43,301

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Taxes [Abstract]	'
Income/(loss) before income taxes	'
	Income before income taxes consists of the following:
		December 31,
		2013			2012			2011
	Domestic	$	23,068		$	13,525		$	3,749
	International		21,939			17,843			16,188
	Total	$	45,007		$	31,368		$	19,937
Provision for income taxes	'
	The provision for income taxes consist of the following provisions/(benefits):
		December 31,
		2013			2012			2011
	Current:
	Federal	$	630		$	(177	)	$	(196	)
	State		15			4			45
	International		5,980			8,525			7,074
			6,625			8,352			6,923
	Deferred:
	Federal	$	7,014		$	(36,287	)	$	204
	International		1,093			(3,926	)		(925	)
			8,107			(40,213	)		(721	)
	Total	$	14,732		$	(31,861	)	$	6,202
Provision for income taxes differs from the statutory federal income tax rate	'
	The provision/(benefit) for income taxes differs from the statutory federal income tax rate of 35% for 2013, 2012 and 2011 as follows:
		December 31,
		2013			2012			2011
	Income tax provision at U.S federal statutory rate	$	15,752		$	10,979		$	6,978
	Effect of foreign income taxed at rates other than the U.S. federal statutory rate		242			(451	)		469
	Foreign income inclusions		-			4,563			8,398
	Tax credits		(250	)		(177	)		(196	)
	Changes in tax laws		(1,155	)		(1,329	)		-
	Indefinite-lived intangibles		-			-			204
	Net change in valuation allowance		(97	)		(45,105	)		(9,546	)
	Other		240			(341	)		(105	)
	Total	$	14,732		$	(31,861	)	$	6,202
Components of deferred tax assets and liabilities	'
	The components of deferred tax assets and liabilities as of December 31, 2013 and 2012 relate to temporary differences and carryforwards as follows:
		December 31,
		2013			2012
	Deferred tax assets:
	Inventory	$	2,510		$	2,263
	Legal and related reserves		260			100
	Foreign tax credit carryforwards		31,463			35,410
	Environmental		2,995			850
	Net capital loss carryforwards (domestic)		31			31
	Net operating loss carryforwards (foreign)		944			902
	Employee benefits		12,841			17,977
	Restructuring		239			334
	Research & experimentation tax credit carryforwards		1,900			1,681
	Alternative minimum tax credit carryforwards		2,773			2,604
	Property, plant and equipment		3,843			4,228
	Other		3,507			4,553
	Total gross deferred tax assets		63,306			70,933
	Valuation allowance		(29,890	)		(29,941	)
	Total deferred tax assets	$	33,416		$	40,992
	Deferred tax liabilities:
	Property, plant and equipment		(9,059	)		(6,523	)
	Intangibles and other		(9,856	)		(9,510	)
	Unremitted foreign earnings		(568	)		(541	)
	Foreign tax allocation reserve		(2,006	)		(2,544	)
	Other		(2,187	)		(2	)
	Total deferred tax liabilities	$	(23,676	)	$	(19,120	)
	Net deferred tax asset / (liability)	$	9,740		$	21,872
	Classified as follows in the consolidated balance sheet:
	Current deferred tax asset (included in other current assets)		2,874			1,469
	Non-current deferred tax asset		19,799			30,786
	Current deferred tax liability (included in other current liabilities)		(98	)		-
	Non-current deferred tax liability		(12,835	)		(10,383	)
		$	9,740		$	21,872
Activity related to the entity's unrecognized tax benefits	'
	The following table summarizes the activity related to the Company’s unrecognized tax benefits as of December 31, 2013, 2012 and 2011:
		2013			2012			2011
	Balance at January 1	$	3,967		$	4,328		$	4,085
	Gross increases related to current period tax positions		257			348			317
	Gross (decreases)/increases related to prior period tax positions		(427	)		(483	)		95
	Expirations of statute of limitations for the assessment of taxes		(37	)		(113	)		(38	)
	Settlements		-			(175	)		-
	Foreign currency translation		162			62			(131	)
	Balance at December 31	$	3,922		$	3,967		$	4,328

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Value Measurements [Abstract]	'
Assets and liabilities carried at fair value measured on recurring basis	'
	The following tables provide the assets and liabilities carried at fair value, measured on a recurring basis, as of December 31, 2013 and 2012:
					Fair Value Measurements at December 31, 2013 using:
	Description	Total			(Level 1)		(Level 2)			(Level 3)
	Interest rate swap, liabilities	$	(616	)	$	-	$	(616	)	$	-
	Total	$	(616	)	$	-	$	(616	)	$	-
					Fair Value Measurements at December 31, 2012 using:
	Description	Total			(Level 1)		(Level 2)			(Level 3)
	Interest rate swap, liabilities	$	(930	)	$	-	$	(930	)	$	-
	Total	$	(930	)	$	-	$	(930	)	$	-

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Income/(Loss) (Tables)	12 Months Ended
	Dec. 31, 2013
Accumulated Other Comprehensive Income/(Loss) [Abstract]	'
Schedule of changes in accumulated other comprehensive income	'
	The following table provides the changes in AOCI by component, net of tax, for the year ended December 31, 2013:
		Foreign Currency Translation Adjustments				Interest Rate Swap			Pension Plans			Total
	Balance as of December 31, 2012	$	5,177			$	(600	)	$	(38,668	)	$	(34,091	)
	Other comprehensive income/(loss) before reclassifications		4,813				(85	)		9,173			13,901
	Amounts reclassified from accumulated other comprehensive loss		-				289			939			1,228
	Net current-period other comprehensive income		4,813				204			10,112			15,129
	Balance as of December 31, 2013	$	9,990			$	(396	)	$	(28,556	)	$	(18,962	)
Reclassifications out of accumulated other comprehensive income	'
	The following table provides the reclassifications out of AOCI by component for the year ended December 31, 2013:
	Details about AOCI Components	Amount Reclassified from AOCI for the year ended December 31, 2013			Affected Line Item in the Consolidated Income Statement
	Losses on cash flow hedge:
	Interest rate swap	$	(444	)	Interest expense, net
		$	155		Tax benefit
		$	(289	)	Net of tax
	Amortization of defined benefit pension items:
	Actuarial losses	$	(1,223	)	Selling, general and administrative expenses
	Actuarial losses		(116	)	Cost of goods sold
	Prior service costs		(50	)	Selling, general and administrative expenses
			(1,389	)	Total before tax
			450		Tax benefit
		$	(939	)	Net of tax
	Total reclassification for the period	$	(1,228	)

Stock_Based_Compensation_Table

Stock Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2013
Stock Based Compensation [Abstract]	'
Assumptions used in determining the fair value of stock options for grants	'
	The following assumptions were used in determining the fair value of stock options for grants issued in 2013, 2012 and 2011:
		2013			2012			2011
	Expected volatility		44.17%-71.58	%		71.84	%		68.91%-71.53	%
	Expected term	1.25-4.75 years			4.75 years			4.75 years
	Risk-free interest rate		0.12%-1.37	%		0.66	%		1.02%-2.00	%
Summary of stock option activity	'
	The following table is a summary of the Company’s stock option activity issued to employees and related information:
					Weighted Average
		Number of Shares			Exercise Price			Options Exercisable
	Outstanding at December 31, 2012		2,264,399			7.02			1,234,623
	Granted		530,835			16.06
	Exercised		(536,565	)		6.01
	Forfeited or expired		(28,700	)		8.99
	Outstanding at December 31, 2013		2,229,969			9.39
	Exercisable at December 31, 2013		1,149,069		$	6.88
Summary of nonvested stock options and restricted stock	'
	A summary of the Company’s nonvested stock options and restricted stock activity is presented below:
		Nonvested Stock Options						Nonvested Restricted Stock
		Number of Shares			Weighted-Average Grant-Date Fair Value			Number of Shares			Weighted-Average Grant-Date Fair Value
	Nonvested at December 31, 2012		1,029,776			4.62			31,145			5.76
	Granted		530,835			7.97			31,648			12.64
	Vested during period		(455,211	)		4.05			(62,793	)		9.23
	Forfeited		(24,500	)		4.73			-			-
	Nonvested at December 31, 2013		1,080,900		$	6.5			-		$	-

Retirement_Plans_Tables

Retirement Plans (Tables)	12 Months Ended
	Dec. 31, 2013
Retirement Plans [Abstract]	'
Benefit obligations	'
	The benefit obligations as of December 31, 2013 and 2012 are as follows:
		Pension Plans
		Domestic						SERP						International
		2013			2012			2013			2012			2013			2012
	Change in benefit obligation
	Benefit obligation, beginning of year	$	79,958		$	75,430		$	3,690		$	4,153		$	27,033		$	23,020
	Service cost		-			-			-			-			743			660
	Interest cost		3,057			3,284			41			85			658			795
	Actuarial (gain)/loss		(8,269	)		4,699			(9	)		88			(2,314	)		1,852
	Benefits paid		(4,037	)		(3,455	)		(636	)		(636	)		(808	)		(755	)
	Currency translation affect		-			-			-			-			315			1,461
	Benefit obligation, end of year	$	70,709		$	79,958		$	3,086		$	3,690		$	25,627		$	27,033
Plan assets and funded status of the Domestic Pension Plan	'
	The plan assets and funded status of the Domestic Pension Plan as of December 31, 2013 and 2012 are as follows:
		2013			2012
	Change in plan assets
	Fair value of plan assets, beginning of period	$	53,900		$	49,104
	Actual return on plan assets		6,894			5,945
	Contributions		986			2,306
	Benefits paid		(4,037	)		(3,455	)
	Fair value of plan assets, end of period	$	57,743		$	53,900
	Unfunded status		(12,966	)		(26,058	)
	Accrued benefit cost, end of period	$	(12,966	)	$	(26,058	)
Amounts recognized in AOCI	'
	The amounts recognized in AOCI as of December 31, 2013 and 2012 consist of the following:
		Pension Plans
		Domestic						SERP						International
		2013			2012			2013			2012			2013			2012
	Actuarial loss	$	20,373		$	32,646		$	830		$	958		$	4,765		$	7,354
	Prior service cost/(benefit)		-			-			230			287			(24	)		(31	)
	Total	$	20,373		$	32,646		$	1,060		$	1,245		$	4,741		$	7,323
Components of net periodic benefit cost	'
	The components of net periodic benefit cost are as follows:
		Pension Plans
		Domestic									SERP									International
		2013			2012			2011			2013			2012			2011			2013			2012			2011
	Components of net periodic benefit cost
	Service cost	$	-		$	-		$	-		$	-		$	-		$	-		$	743		$	660		$	611
	Interest cost		3,057			3,284			3,462			41			85			150			658			795			944
	Expected return on plan assets		(3,826	)		(3,674	)		(3,787	)		-			-			-			-			-			-
	Amortization of prior service cost/(benefit)		-			60			436			57			57			57			(7	)		(7	)		(7	)
	Recognized actuarial loss		937			864			458			118			76			49			284			200			111
	Net periodic benefit cost	$	168		$	534		$	569		$	216		$	218		$	256		$	1,678		$	1,648		$	1,659
Estimated amounts that will be amortized from AOCI into net periodic benefit cost in 2014	'
	The estimated amounts that will be amortized from AOCI into net periodic benefit cost in 2014 are as follows:
		Pension Plans
		Domestic			SERP			International
	Actuarial loss	$	522		$	131		$	160
	Prior service cost/(benefit)		-			57			(7	)
	Total	$	522		$	188		$	153
Major assumptions used in determining the benefit obligations and net benefit cost	'
	Major assumptions used in determining the benefit obligations are presented in the following table:
		2013			2012
	Discount rate:
	Domestic Pension Plan		4.8	%		3.9	%
	SERP		1.4	%		1.35	%
	International Pension Plan		3.7	%		3.4	%
	Rate of compensation increase:
	International Pension Plan		2.5	%		2.4	%
	Major assumptions used in determining the net benefit cost are presented in the following table:
		2013			2012			2011
	Discount rate:
	Domestic Pension Plan		3.9	%		4.45	%		5.35	%
	SERP		1.35	%		2.4	%		3.4	%
	International Pension Plan		3.4	%		3.4	%		4.4	%
	Expected return on plan assets:
	Domestic Pension Plan		7.25	%		7.5	%		7.5	%
	Rate of compensation increase:
	International Pension Plan		2.5	%		2.4	%		2.8	%
Expected benefit payments	'
	The following benefit payments are expected to be paid out of the plans:
		Pension Plans
		Domestic			SERP			International
	2014	$	3,527		$	731		$	824
	2015	$	3,478		$	609		$	836
	2016	$	3,486		$	609		$	837
	2017	$	3,628		$	609		$	858
	2018	$	3,654		$	609		$	934
	2019-2023	$	21,028			-		$	5,681
Fair values of the Company's pension plan assets by asset category	'
	The fair values of the Company’s pension plan assets by asset category are as follows:
					Fair Value Measurements at December 31, 2013 using:
	Asset Category	Total			(Level 1)			(Level 2)			(Level 3)
	Equity securities:
	U.S. companies	$	20,633		$	-		$	20,633		$	-
	International companies		11,157			-			11,157			-
	U.S. fixed income		18,736			-			16,660			2,076
	Commodities		4,436			-			4,436			-
	TIPS		2,781			-			2,781			-
		$	57,743		$	-		$	55,667		$	2,076
					Fair Value Measurements at December 31, 2012 using:
	Asset Category	Total			(Level 1)			(Level 2)			(Level 3)
	Equity securities:
	U.S. companies	$	19,238		$	-		$	19,238		$	-
	International companies		10,337			-			10,337			-
	U.S. fixed income		17,625			-			15,465			2,160
	Commodities		4,131			-			4,131			-
	TIPS		2,569			-			2,569			-
		$	53,900		$	-		$	51,740		$	2,160
Changes in the fair value of the Domestic Plan's Level 3 assets	'
	The following table sets forth a summary of the changes in the fair value of the Domestic Plan’s Level 3 assets, which are annuity contracts with an insurance company, for the year ended December 31, 2013:
		Group Annuity Contract
	Balance at December 31, 2012	$	2,160
	Net investment loss		(84	)
	Balance at December 31, 2013	$	2,076

Foreign_Operations_and_Sales_T

Foreign Operations and Sales (Tables)	12 Months Ended
	Dec. 31, 2013
Foreign Operations and Sales [Abstract]	'
Gross sales and long lived tangible assets for the entity's domestic and foreign entities	'
	The following summarized data represents the gross sales and long lived assets for the Company’s domestic and foreign entities for 2013, 2012 and 2011:
		Domestic		Foreign		Total
	2013
	Gross sales	$	153,202	$	164,010	$	317,212
	Long-lived assets		59,496		155,151		214,647
	2012
	Gross sales	$	109,729	$	168,202	$	277,931
	Long-lived assets		44,085		149,133		193,218
	2011
	Gross sales	$	83,407	$	171,068	$	254,475
	Long-lived assets		34,885		145,735		180,620
Sales to geographic area	'
	Sales to geographic area consist of the following:
		2013		2012		2011
	Europe	$	210,463	$	150,678	$	156,814
	North America		86,974		105,439		75,979
	Asia		13,800		12,827		10,448
	Other		5,975		8,987		11,234
	Total	$	317,212	$	277,931	$	254,475

Commitments_Tables

Commitments (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments [Abstract]	'
Future minimum commitments under non-cancelable operating lease arrangements	'
	The Company has operating leases expiring on various dates through the year 2019. The leases are primarily for the rental of office space, office and laboratory equipment and vehicles. At December 31, 2013, future minimum commitments under non-cancelable operating lease arrangements were as follows:
	Year ended December 31:
	2014	$	968
	2015		830
	2016		539
	2017		515
	2018		442
	2019 and thereafter		101
	Total commitments	$	3,395
Future commitments under unconditional purchase obligations	'
	The Company is party to several unconditional purchase obligations resulting from contracts that contain legally binding provisions with respect to quantities, pricing and timing of purchases. The Company’s purchase obligations mainly include commitments to purchase utilities. At December 31, 2013, future commitments under these obligations were as follows:
	Year ended December 31:
	2014	$	2,171
	2015		598
	2016		-
	2017		-
	2018		-
	Total commitments	$	2,769

SELECTED_QUARTERLY_FINANCIAL_A1

SELECTED QUARTERLY FINANCIAL AND SUPPLEMENTARY DATA - UNAUDITED (Tables)	12 Months Ended
	Dec. 31, 2013
SELECTED QUARTERLY FINANCIAL AND SUPPLEMENTARY DATA - UNAUDITED [Abstract]	'
Schedule of selected quarterly financial and supplementary data	'
	SELECTED QUARTERLY FINANCIAL AND SUPPLEMENTARY DATA - UNAUDITED
	(in thousands, except share and per share data)
			1st			2nd			3rd			4th
			Quarter (1)			Quarter			Quarter			Quarter
	2013
	Gross sales		$	74,581		$	61,628		$	77,992		$	103,011
	Net revenues			74,885			62,803			77,452			103,036
	Gross profit			24,749			19,251			24,966			33,938
	Income from continuing operations			11,425			3,136			6,274			9,440
	Loss from discontinued operations (3)			(257	)		(862	)		(2,700	)		(541	)
	Net income			11,168			2,274			3,574			8,899
	Earnings per share of common stock: (4)
	Basic			0.37			0.07			0.12			0.29
	Diluted			0.36			0.07			0.12			0.29
	Average shares:
	Basic			29,970			30,089			30,184			30,353
	Diluted			30,788			30,956			31,052			31,166
			1st			2nd			3rd			4th
			Quarter			Quarter			Quarter			Quarter (2)
	2012
	Gross sales		$	70,559		$	77,142		$	59,841		$	70,389
	Net revenues			70,228			77,133			59,210			69,930
	Gross profit			22,428			28,445			18,531			21,083
	Income from continuing operations			7,038			9,928			2,021			44,242
	Loss from discontinued operations (3)			-			-			(332	)		(594	)
	Net income			7,038			9,928			1,689			43,648
	Earnings per share of common stock: (4)
	Basic			0.24			0.34			0.06			1.46
	Diluted			0.24			0.33			0.06			1.42
	Average shares:
	Basic			29,602			29,623			29,711			29,874
	Diluted			29,886			29,912			30,587			30,717
	-1	Income from continuing operations includes a gain on sale of an office building of $4,680 and a corresponding tax expense of $1,470 and a benefit of $1,155 due to changes in tax laws.
	-2	Income from continuing operations includes the reversal of a valuation allowance on deferred tax assets of $36,287 and the impact on deferred taxes of a statutory rate change of $1,328.
	-3	Discontinued operations include charges for environmental remediation related to sites of divested businesses.
	-4	Earnings per share calculations for each of the quarters are based on the weighted average number of shares outstanding for each period. As such, the sum of the quarters may not necessarily equal the earnings per share amount for the year.

The_Company_Details

The Company (Details)	12 Months Ended
	Dec. 31, 2013
	Segment
The Company [Abstract]	'
Number of operating segments	3
Number of reportable segments	1

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash Equivalents [Abstract]	'	'	'
Original maturity period of temporary cash investments considered as cash equivalents, maximum	'3 months	'	'
Summary of estimated useful lives for each asset group [Abstract]	'	'	'
Total interest capitalized	$298	'	'
Income taxes [Abstract]	'	'	'
Deferred tax liability on undistributed foreign earnings	568	541	'
Foreign Currency [Abstract]	'	'	'
Foreign currency net transaction losses	133	274	62
Earnings per Common Share [Abstract]	'	'	'
Antidilutive securities excluded from computation of earnings per share (in shares)	916,350	580,745	1,839,373
Components of accumulated other comprehensive loss in stockholders' equity [Abstract]	'	'	'
Foreign currency translation	9,990	5,177	'
Unrealized loss on hedging contracts, net of tax	-396	-600	'
Pensions, net of tax	-28,556	-38,668	'
Total	-18,962	-34,091	'
Minimum [Member]	'	'	'
Concentrations of credit risk [Abstract]	'	'	'
Cash balances with European Union banks	5,000	'	'
Minimum [Member] | Buildings and improvements [Member]	'	'	'
Summary of estimated useful lives for each asset group [Abstract]	'	'	'
Estimated useful lives	'20 years	'	'
Minimum [Member] | Machinery and equipment [Member]	'	'	'
Summary of estimated useful lives for each asset group [Abstract]	'	'	'
Estimated useful lives	'7 years	'	'
Minimum [Member] | Furniture and fixtures [Member]	'	'	'
Summary of estimated useful lives for each asset group [Abstract]	'	'	'
Estimated useful lives	'5 years	'	'
Minimum [Member] | Computer hardware and software [Member]	'	'	'
Summary of estimated useful lives for each asset group [Abstract]	'	'	'
Estimated useful lives	'3 years	'	'
Maximum [Member]	'	'	'
Concentrations of credit risk [Abstract]	'	'	'
Cash balances with European Union banks	$15,000	'	'
Maximum [Member] | Buildings and improvements [Member]	'	'	'
Summary of estimated useful lives for each asset group [Abstract]	'	'	'
Estimated useful lives	'30 years	'	'
Maximum [Member] | Machinery and equipment [Member]	'	'	'
Summary of estimated useful lives for each asset group [Abstract]	'	'	'
Estimated useful lives	'15 years	'	'
Maximum [Member] | Furniture and fixtures [Member]	'	'	'
Summary of estimated useful lives for each asset group [Abstract]	'	'	'
Estimated useful lives	'7 years	'	'
Maximum [Member] | Computer hardware and software [Member]	'	'	'
Summary of estimated useful lives for each asset group [Abstract]	'	'	'
Estimated useful lives	'7 years	'	'

Net_Inventories_Details

Net Inventories (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Inventory, Net [Abstract]	'	'
Finished goods	$29,797	$30,262
Work in process	31,990	23,533
Raw materials	22,580	12,352
Supplies	5,598	5,074
Total	89,965	71,221
Inventory reserves	$11,496	$11,839

Property_Plant_and_Equipment_D

Property, Plant and Equipment (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Schedule of Property, plant and equipment [Abstract]	'	'	'
Land	$4,312	$4,221	'
Buildings and Improvements	108,460	92,307	'
Machinery and equipment	398,490	364,370	'
Furniture and fixtures	1,884	1,813	'
Construction in progress	16,808	21,382	'
Total	529,954	484,093	'
Accumulated depreciation	-357,988	-332,278	'
Net	171,966	151,815	'
Depreciation expense	22,218	21,528	22,822
Total capital expenditures	$41,600	$29,407	'

Goodwill_and_Intangible_Assets2

Goodwill and Intangible Assets (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Goodwill [Roll Forward]	'	'	'
Beginning Balance	$37,312	$36,731	'
Translation effect	1,358	581	'
Ending Balance	38,670	37,312	36,731
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'
Gross Carrying Amount	5,006	4,789	'
Accumulated Amortization	-995	-698	'
Net Carrying Amount	4,011	4,091	'
Amortization expense	255	247	298
Finite-Lived Intangible Assets, Net, Amortization Expense, Rolling Maturity [Abstract]	'	'	'
Amortization expense for current intangible assets, for year one	265	'	'
Amortization expense for current intangible assets, for year two	265	'	'
Amortization expense for current intangible assets, for year three	265	'	'
Amortization expense for current intangible assets, for year four	265	'	'
Amortization expense for current intangible assets, for year five	265	'	'
Technology-based intangibles [Member]	'	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'
Amortization Period	'20 years	'20 years	'
Gross Carrying Amount	4,192	4,011	'
Accumulated Amortization	-786	-552	'
Net Carrying Amount	3,406	3,459	'
Customer related intangibles [Member]	'	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'
Gross Carrying Amount	814	778	'
Accumulated Amortization	-209	-146	'
Net Carrying Amount	$605	$632	'
Customer related intangibles [Member] | Minimum [Member]	'	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'
Amortization Period	'10 years	'10 years	'
Customer related intangibles [Member] | Maximum [Member]	'	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'
Amortization Period	'15 years	'15 years	'

Investments_in_and_Advances_to1

Investments in and Advances to Partially-Owned Affiliates (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract]	'	'	'
Entity's proportionate share of net income/(loss) from equity method investments	($2,262)	($1,766)	($1,621)
Advances to partially-owned affiliates	-1,655	-2,047	0
Zenara Pharma [Member]	'	'	'
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract]	'	'	'
Equity method investment, ownership percentage (in hundredths)	51.00%	'	'
Remaining ownership percentage to be purchased in the future (in hundredths)	49.00%	'	'
Entity's proportionate share of net income/(loss) from equity method investments	-1,956	-1,976	-1,621
Entity's proportionate share of amortization expense from equity method investments	882	965	1,106
Entity's proportionate share of depreciation expense from equity method investments	130	132	149
Advances to partially-owned affiliates	-1,514	-1,594	'
European Joint Venture [Member]	'	'	'
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract]	'	'	'
Entity's proportionate share of net income/(loss) from equity method investments	-311	210	'
Advances to partially-owned affiliates	($141)	($453)	'

Accrued_Expense_and_Other_Curr2

Accrued Expense and Other Current Liabilities (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Accrued Expenses And Other Current Liabilities [Abstract]	'	'
Salaries and employee benefits payable	$26,211	$23,882
Taxes payable and related reserves	10,168	9,637
Other	11,719	9,782
Total	$48,098	$43,301

Income_Taxes_Details

Income Taxes (Details) (USD $)

12 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Minimum [Member]

Maximum [Member]

Foreign Valuation Allowance [Member]

Foreign Valuation Allowance [Member]

Foreign Valuation Allowance [Member]

Domestic Gains and Losses Included in OCI and Discontinued Operations [Member]

Domestic Gains and Losses Included in OCI and Discontinued Operations [Member]

Domestic Valuation Allowance [Member]

Domestic Valuation Allowance [Member]

Domestic Valuation Allowance [Member]

Foreign Gains and Losses Related to Deferred Taxes and Currency Translation Adjustments Included in OCI [Member]

Foreign Gains and Losses Related to Deferred Taxes and Currency Translation Adjustments Included in OCI [Member]

Foreign Gains and Losses Related to Deferred Taxes and Currency Translation Adjustments Included in OCI [Member]

Domestic Valuation Allowance Release of Valuation Allowance Due to Profitability [Member]

Domestic Valuation Allowance Income and Deferred Tax Amounts in Continuing Operations Prior to the Release of the Valuation Allowance in the Fourth Quarter of 2012 [Member]

Foreign Valuation Allowance Change for Income Loss [Member]

Foreign Valuation Allowance Change for Income Loss [Member]

Foreign Valuation Allowance Change for Income Loss [Member]

Domestic Valuation Allowance Change for Income Loss [Member]

Foreign Operating Loss Carryforward [Member]

Non-US Jurisdiction [Member]

Foreign Operating Loss Acquired in 2010 [Member]

Income/(loss) before income taxes [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Domestic

$23,068

$13,525

$3,749

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

International

21,939

17,843

16,188

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Income before income taxes

45,007

31,368

19,937

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Current [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Federal

630

-177

-196

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

State

15

4

45

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

International

5,980

8,525

7,074

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Current, Total

6,625

8,352

6,923

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deferred [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Federal

7,014

-36,287

204

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

International

1,093

-3,926

-925

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deferred, Total

8,107

-40,213

-721

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total

14,732

-31,861

6,202

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Statutory federal income tax rate (in hundredths)

35.00%

35.00%

35.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Provision for income taxes differs from the statutory federal income tax rate [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Income tax provision at U.S federal statutory rate

15,752

10,979

6,978

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Effect of foreign income taxed at rates other than the U.S. federal statutory rate

242

-451

469

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Foreign income inclusions

0

4,563

8,398

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Tax credits

-250

-177

-196

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Change in tax laws

-1,155

-1,329

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Indefinite-lived intangibles

0

0

204

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net change in valuation allowance

-97

-45,105

-9,546

'

'

-48

-140

-582

-2,543

9,644

-3

-47,490

304

46

18

-376

-36,287

-8,660

-94

-158

-206

-9,340

'

'

'

Other

240

-341

-105

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total

14,732

-31,861

6,202

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deferred tax assets [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Inventory

2,510

2,263

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Legal and related reserves

260

100

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Foreign tax credit carryforwards

31,463

35,410

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Environmental

2,995

850

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net capital loss carryforwards (domestic)

31

31

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net operating loss carryforwards (foreign)

944

902

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee benefits

12,841

17,977

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restructuring

239

334

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Research & experimentation tax credit carryforwards

1,900

1,681

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Alternative minimum tax credit carryforwards

2,773

2,604

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Property, plant and equipment

3,843

4,228

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other

3,507

4,553

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total gross deferred tax assets

63,306

70,933

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Valuation allowances

-29,890

-29,941

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total deferred tax assets

33,416

40,992

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deferred tax liabilities [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Property, plant and equipment

-9,059

-6,523

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Intangibles and other

-9,856

-9,510

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unremitted foreign earnings

-568

-541

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Foreign tax allocation reserve

-2,006

-2,544

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other

-2,187

-2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total deferred tax liabilities

-23,676

-19,120

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net deferred tax asset / (liability)

9,740

21,872

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Classified as follows in the consolidated balance sheet: [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Current deferred tax asset (included in other current assets)

2,874

1,469

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Non-current deferred tax asset

19,799

30,786

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Current deferred tax liability (included in other current liabilities)

-98

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Non-current deferred tax liability

-12,835

-10,383

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Operating Loss Carryforwards [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Operating loss carryforwards

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,356

'

'

Acquired operating loss carryforwards

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,090

Foreign earnings repatriated

0

8,953

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Valuation Allowance [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net change in valuation allowance

-97

-45,105

-9,546

'

'

-48

-140

-582

-2,543

9,644

-3

-47,490

304

46

18

-376

-36,287

-8,660

-94

-158

-206

-9,340

'

'

'

Activity related to the entity's unrecognized tax benefits [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Balance at January 1

3,967

4,328

4,085

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gross increases related to current period tax positions

257

348

317

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gross increases/(decreases) related to prior period tax positions

-427

-483

95

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expirations of statute of limitations for the assessment of taxes

-37

-113

-38

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Settlements

0

-175

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Foreign currency translation

162

62

-131

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Balance at December 31

3,922

3,967

4,328

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unrecognized tax benefits that would affect effective tax rate

3,922

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gross interest and penalties related to unrecognized tax benefits

5,005

4,511

3,427

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest and penalties

219

985

328

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Income Tax Contingency [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Increase in reserve for unrecognized tax benefits

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

450

'

Amount in which the reserve for unrecognized tax benefits changed due to foreign currency translation

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

279

'

Potential future increase in reserve for unrecognized tax benefits for intercompany transactions and acquired tax attributes

500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Potential future increase/(decrease) to unrecognized tax benefits

'

'

'

($6,400)

$8,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Longterm_Debt_Details

Long-term Debt (Details) (USD $)	1 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Nov. 30, 2011	Dec. 31, 2013	Dec. 31, 2012
Line of Credit Facility [Line Items]	'	'	'
Weighted average interest rate of long-term bank debt (in hundredths)	'	2.30%	2.20%
Syndicated Senior Revolving Credit Facility [Member]	'	'	'
Line of Credit Facility [Line Items]	'	'	'
Borrowing capacity	$250,000	'	'
Term of revolving credit facility	'5 years	'	'
Expiration date of revolving credit facility	30-Nov-16	'	'
Variable rate of credit facility	'	'LIBOR	'
Outstanding credit facility	'	$79,250	$64,000
Syndicated Senior Revolving Credit Facility [Member] | Minimum [Member]	'	'	'
Line of Credit Facility [Line Items]	'	'	'
Basis spread (in hundredths)	'	1.75%	'
Syndicated Senior Revolving Credit Facility [Member] | Maximum [Member]	'	'	'
Line of Credit Facility [Line Items]	'	'	'
Basis spread (in hundredths)	'	2.50%	'

Derivatives_and_Hedging_Activi1

Derivatives and Hedging Activities (Details) (Interest Rate Swap [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Interest Rate Swap [Member]	'	'
Interest rate swap agreement [Abstract]	'	'
Notional amount of cash flow hedge instruments	$60,000	'
Maturity date	28-Sep-15	'
Interest rate swap, fixed rate (in hundredths)	0.92%	'
Fair value of swap	-616	-930
Interest rate cash flow hedge gain (loss) to be reclassified during next 12 months, net	($420)	'

Fair_Value_Measurements_Detail

Fair Value Measurements (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Interest rate swap, liabilities	($616)	($930)
Total	-616	-930
(Level 1) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Interest rate swap, liabilities	0	0
Total	0	0
(Level 2) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Interest rate swap, liabilities	-616	-930
Total	-616	-930
(Level 3) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Interest rate swap, liabilities	0	0
Total	$0	$0

Stockholders_Equity_Details

Stockholders' Equity (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Class of Stock [Line Items]	'	'
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, par value (in dollars per share)	$0.10	$0.10
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, par value (in dollars per share)	$0.10	$0.10
Preferred stock, shares outstanding (in shares)	0	0
Treasury stock (in shares)	1,757,530	1,795,082
Common stock reserved for issuance (in shares)	1,251,625	'
Nonvoting Common Stock [Member]	'	'
Class of Stock [Line Items]	'	'
Common stock, shares authorized (in shares)	730,746	730,746
Common stock, par value (in dollars per share)	$0.10	$0.10
Common stock, shares outstanding (in shares)	0	0
Common Stock [Member]	'	'
Class of Stock [Line Items]	'	'
Common stock, shares authorized (in shares)	100,000,000	100,000,000

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Income/(Loss) (Details) (USD $)

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Changes In accumulated other comprehensive income [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

Beginning balance

'

'

'

($34,091)

'

'

'

'

($34,091)

'

'

Other comprehensive income/(loss) before reclassifications

'

'

'

'

'

'

'

'

13,901

'

'

Amounts reclassified from accumulated other comprehensive loss

'

'

'

'

'

'

'

'

1,228

'

'

Net current-period other comprehensive income

'

'

'

'

'

'

'

'

15,129

-2,504

-19,695

Ending balance

-18,962

'

'

'

-34,091

'

'

'

-18,962

-34,091

'

Amount Reclassified from AOCI [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Interest expense, net

'

'

'

'

'

'

'

'

-2,242

-2,439

-2,373

Selling, general and administrative expenses

'

'

'

'

'

'

'

'

-47,568

-45,248

-39,227

Cost of goods sold

'

'

'

'

'

'

'

'

-215,272

-186,014

-181,569

Net income

8,899

3,574

2,274

11,168

[1]

43,648

[2]

1,689

9,928

7,038

25,915

62,303

10,968

Amounts reclassified from accumulated other comprehensive income [Member]

'

'

'

'

'

'

'

'

'

'

'

Amount Reclassified from AOCI [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Net income

'

'

'

'

'

'

'

'

-1,228

'

'

Foreign Currency Translation Adjustments [Member]

'

'

'

'

'

'

'

'

'

'

'

Changes In accumulated other comprehensive income [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

Beginning balance

'

'

'

5,177

'

'

'

'

5,177

'

'

Other comprehensive income/(loss) before reclassifications

'

'

'

'

'

'

'

'

4,813

'

'

Amounts reclassified from accumulated other comprehensive loss

'

'

'

'

'

'

'

'

0

'

'

Net current-period other comprehensive income

'

'

'

'

'

'

'

'

4,813

'

'

Ending balance

9,990

'

'

'

'

'

'

'

9,990

'

'

Interest Rate Swap [Member]

'

'

'

'

'

'

'

'

'

'

'

Changes In accumulated other comprehensive income [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

Beginning balance

'

'

'

-600

'

'

'

'

-600

'

'

Other comprehensive income/(loss) before reclassifications

'

'

'

'

'

'

'

'

-85

'

'

Amounts reclassified from accumulated other comprehensive loss

'

'

'

'

'

'

'

'

289

'

'

Net current-period other comprehensive income

'

'

'

'

'

'

'

'

204

'

'

Ending balance

-396

'

'

'

'

'

'

'

-396

'

'

Amount Reclassified from AOCI [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Interest expense, net

'

'

'

'

'

'

'

'

-444

'

'

Tax benefit

'

'

'

'

'

'

'

'

155

'

'

Net of Tax

'

'

'

'

'

'

'

'

-289

'

'

Pension Plans [Member]

'

'

'

'

'

'

'

'

'

'

'

Changes In accumulated other comprehensive income [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

Beginning balance

'

'

'

-38,668

'

'

'

'

-38,668

'

'

Other comprehensive income/(loss) before reclassifications

'

'

'

'

'

'

'

'

9,173

'

'

Amounts reclassified from accumulated other comprehensive loss

'

'

'

'

'

'

'

'

939

'

'

Net current-period other comprehensive income

'

'

'

'

'

'

'

'

10,112

'

'

Ending balance

-28,556

'

'

'

'

'

'

'

-28,556

'

'

Amount Reclassified from AOCI [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Total before tax

'

'

'

'

'

'

'

'

-1,389

'

'

Tax benefit

'

'

'

'

'

'

'

'

450

'

'

Net of Tax

'

'

'

'

'

'

'

'

-939

'

'

Actuarial Loss [Member]

'

'

'

'

'

'

'

'

'

'

'

Amount Reclassified from AOCI [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Selling, general and administrative expenses

'

'

'

'

'

'

'

'

-1,223

'

'

Cost of goods sold

'

'

'

'

'

'

'

'

-116

'

'

Prior Service Cost [Member]

'

'

'

'

'

'

'

'

'

'

'

Amount Reclassified from AOCI [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Selling, general and administrative expenses

'

'

'

'

'

'

'

'

($50)

'

'

[1]

Income from continuing operations includes a gain on sale of an office building of $4,680 and a corresponding tax expense of $1,470 and a benefit of $1,155 due to changes in tax laws.

[2]

Income from continuing operations includes the reversal of a valuation allowance on deferred tax assets of $36,287 and the impact on deferred taxes of a statutory rate change of $1,328.

Stock_Based_Compensation_Detai

Stock Based Compensation (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Expected volatility (in hundredths)	'	71.84%	'
Expected term	'	'4 years 9 months	'4 years 9 months
Risk-free interest rate (in hundredths)	'	0.66%	'
Minimum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Expected volatility (in hundredths)	44.17%	'	68.91%
Expected term	'1 year 3 months	'	'
Risk-free interest rate (in hundredths)	0.12%	'	1.02%
Maximum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Expected volatility (in hundredths)	71.58%	'	71.53%
Expected term	'4 years 9 months	'	'
Risk-free interest rate (in hundredths)	1.37%	'	2.00%
Stock Options [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Weighted-average fair value per share (in dollars per share)	$7.97	$7.14	$3.18
Number of Shares [Roll Forward]	'	'	'
Outstanding, beginning balance (in shares)	2,264,399	'	'
Granted (in shares)	530,835	'	'
Exercised (in shares)	-536,565	'	'
Forfeited or expired (in shares)	-28,700	'	'
Outstanding, ending balance (in shares)	2,229,969	2,264,399	'
Options exercisable (in shares)	1,149,069	1,234,623	'
Weighted Average Exercise Price [Roll Forward]	'	'	'
Outstanding, beginning balance (in dollars per share)	$7.02	'	'
Granted (in dollars per share)	$16.06	'	'
Exercised (in dollars per share)	$6.01	'	'
Forfeited or expired (in dollars per share)	$8.99	'	'
Outstanding, ending balance (in dollars per share)	$9.39	$7.02	'
Exercisable, ending balance (in dollars per share)	$6.88	'	'
Aggregate intrinsic value exercised	$5,017	$1,658	$70
Aggregate intrinsic value outstanding	18,827	'	'
Aggregate intrinsic value exercisable	12,585	'	'
Stock Options [Member] | Selling, General and Administrative Expenses [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Stock option expense	1,994	1,303	1,028
Stock Options [Member] | Unvested [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Total compensation cost related to unvested share-based awards not yet recognized	6,436	'	'
Weighted average vesting period	'2 years 9 months 18 days	'	'
Restricted Stock [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Performance period	'6 months	'	'
Nonvested Restricted Stock Number of Shares [Roll Forward]	'	'	'
Nonvested, beginning balance (in shares)	31,145	'	'
Granted (in shares)	31,648	'	'
Vested during period (in shares)	-62,793	'	'
Forfeited (in shares)	0	'	'
Nonvested, ending balance (in shares)	0	'	'
Nonvested Restricted Stock, Weighted-Average Grant-Date Fair Value [Roll Forward]	'	'	'
Nonvested, beginning balance (in dollars per share)	$5.76	'	'
Granted (in dollars per share)	$12.64	'	'
Vested during period (in dollars per share)	$9.23	'	'
Forfeited (in dollars per share)	$0	'	'
Nonvested, ending balance (in dollars per share)	$0	'	'
Restricted Stock [Member] | Selling, General and Administrative Expenses [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Restricted stock expense	427	446	497
Nonvested Stock Option [Member]	'	'	'
Nonvested Stock Options, Number of Shares [Roll Forward]	'	'	'
Nonvested, beginning balance (in shares)	1,029,776	'	'
Granted (in shares)	530,835	'	'
Vested during period (in shares)	-455,211	'	'
Forfeited (in shares)	-24,500	'	'
Nonvested, ending balance (in shares)	1,080,900	'	'
Nonvested Stock Options, Weighted-Average Grant-Date Fair Value [Roll Forward]	'	'	'
Nonvested, beginning balance (in dollars per share)	$4.62	'	'
Granted (in dollars per share)	$7.97	'	'
Vested during period (in dollars per share)	$4.05	'	'
Forfeited (in dollars per share)	$4.73	'	'
Nonvested, ending balance (in dollars per share)	$6.50	'	'
Performance shares [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Performance period	'3 years	'	'
Performance shares [Member] | Selling, General and Administrative Expenses [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Performance share expense	404	53	40
Cash Settled Performance Share units [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Performance period	'3 years	'	'
Cash Settled Performance Share units [Member] | Selling, General and Administrative Expenses [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Performance share unit expense	$2,620	$1,529	$415

Retirement_Plans_Details

Retirement Plans (Details) (USD $)	1 Months Ended	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Jan. 31, 2009	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	Installment
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Number of actuarial equivalent installments	10	'	'	'
Cost of defined contribution plan	'	$731	$733	$604
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	57,743	53,900	'
Deferred Compensation Plan [Member]	'	'	'	'
Deferred Compensation Plan Disclosure [Line Items]	'	'	'	'
Obligation under deferred compensation plan included in other liabilities	'	1,049	1,118	'
Investment in mutual funds included in other assets	'	1,049	1,118	'
Common shares held in trust (in shares)	'	49,121	49,121	'
Common shares held in trust, value	'	876	559	'
(Level 1) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	0	0	'
(Level 2) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	55,667	51,740	'
(Level 3) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	2,076	2,160	'
Domestic and International Equity Securities [Member]	'	'	'	'
Defined Benefit Plan, Assets, Target Allocations [Abstract]	'	'	'	'
Target plan asset allocations range minimum (in hundredths)	'	30.00%	'	'
Target plan asset allocations range maximum (in hundredths)	'	80.00%	'	'
Equity Securities U.S. Companies [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	20,633	19,238	'
Equity Securities U.S. Companies [Member] | (Level 1) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	0	0	'
Equity Securities U.S. Companies [Member] | (Level 2) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	20,633	19,238	'
Equity Securities U.S. Companies [Member] | (Level 3) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	0	0	'
Equity Securities International Companies [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	11,157	10,337	'
Equity Securities International Companies [Member] | (Level 1) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	0	0	'
Equity Securities International Companies [Member] | (Level 2) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	11,157	10,337	'
Equity Securities International Companies [Member] | (Level 3) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	0	0	'
U.S. fixed income [Member]	'	'	'	'
Defined Benefit Plan, Assets, Target Allocations [Abstract]	'	'	'	'
Target plan asset allocations range minimum (in hundredths)	'	25.00%	'	'
Target plan asset allocations range maximum (in hundredths)	'	45.00%	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	18,736	17,625	'
U.S. fixed income [Member] | (Level 1) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	0	0	'
U.S. fixed income [Member] | (Level 2) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	16,660	15,465	'
U.S. fixed income [Member] | (Level 3) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	2,076	2,160	'
All other investments [Member]	'	'	'	'
Defined Benefit Plan, Assets, Target Allocations [Abstract]	'	'	'	'
Target plan asset allocations range minimum (in hundredths)	'	0.00%	'	'
Target plan asset allocations range maximum (in hundredths)	'	10.00%	'	'
Commodities [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	4,436	4,131	'
Commodities [Member] | (Level 1) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	0	0	'
Commodities [Member] | (Level 2) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	4,436	4,131	'
Commodities [Member] | (Level 3) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	0	0	'
TIPS [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	2,781	2,569	'
TIPS [Member] | (Level 1) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	0	0	'
TIPS [Member] | (Level 2) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	2,781	2,569	'
TIPS [Member] | (Level 3) [Member]	'	'	'	'
Fair values of pension plan assets by asset category [Abstract]	'	'	'	'
Fair value of plan assets	'	0	0	'
Domestic [Member]	'	'	'	'
Change in benefit obligation	'	'	'	'
Benefit obligation, beginning of year	'	79,958	75,430	'
Service cost	'	0	0	0
Interest cost	'	3,057	3,284	3,462
Actuarial (gain)/loss	'	-8,269	4,699	'
Benefits paid	'	-4,037	-3,455	'
Currency translation affect	'	0	0	'
Benefit obligation, end of year	'	70,709	79,958	75,430
Change in plan assets	'	'	'	'
Fair value of plan assets, beginning of period	'	53,900	49,104	'
Actual return on plan assets	'	6,894	5,945	'
Contributions	'	986	2,306	'
Benefits paid	'	-4,037	-3,455	'
Fair value of plan assets, end of period	'	57,743	53,900	49,104
Unfunded status	'	-12,966	-26,058	'
Accrued benefit cost, end of period	'	-12,966	-26,058	'
Amounts recognized in AOCI [Abstract]	'	'	'	'
Actuarial loss	'	20,373	32,646	'
Prior service cost/(benefit)	'	0	0	'
Total	'	20,373	32,646	'
Components of net periodic benefit cost [Abstract]	'	'	'	'
Service cost	'	0	0	0
Interest cost	'	3,057	3,284	3,462
Expected return on plan assets	'	-3,826	-3,674	-3,787
Amortization of prior service cost/(benefit)	'	0	60	436
Recognized actuarial loss	'	937	864	458
Net periodic benefit cost	'	168	534	569
Estimated amounts that will be amortized from AOCI into net periodic benefit cost in 2014 [Abstract]	'	'	'	'
Actuarial loss	'	522	'	'
Prior service cost/(benefit)	'	0	'	'
Total	'	522	'	'
Major assumptions used in determining the benefit obligations [Abstract]	'	'	'	'
Discount rate (in hundredths)	'	4.80%	3.90%	'
Major assumptions used in determining the net benefit cost [Abstract]	'	'	'	'
Discount rate (in hundredths)	'	3.90%	4.45%	5.35%
Expected return on plan assets (in hundredths)	'	7.25%	7.50%	7.50%
Aggregate accumulated benefit obligation	'	70,709	'	'
Aggregate ABO exceeds plan assets	'	12,966	'	'
Expected contribution in cash to Domestic Pension Plan in 2014	'	2,700	'	'
Benefit payments expected to be paid out of the plans [Abstract]	'	'	'	'
2014	'	3,527	'	'
2015	'	3,478	'	'
2016	'	3,486	'	'
2017	'	3,628	'	'
2018	'	3,654	'	'
2019-2023	'	21,028	'	'
Domestic [Member] | (Level 3) [Member]	'	'	'	'
Summary of the changes in the fair value of the Domestic Plans Level 3 assets [Abstract]	'	'	'	'
Fair value of plan assets, beginning of period	'	2,160	'	'
Net investment loss	'	-84	'	'
Fair value of plan assets, end of period	'	2,076	'	'
International [Member]	'	'	'	'
Change in benefit obligation	'	'	'	'
Benefit obligation, beginning of year	'	27,033	23,020	'
Service cost	'	743	660	611
Interest cost	'	658	795	944
Actuarial (gain)/loss	'	-2,314	1,852	'
Benefits paid	'	-808	-755	'
Currency translation affect	'	315	1,461	'
Benefit obligation, end of year	'	25,627	27,033	23,020
Change in plan assets	'	'	'	'
Benefits paid	'	-808	-755	'
Unfunded status	'	-25,627	-27,033	'
Amounts recognized in AOCI [Abstract]	'	'	'	'
Actuarial loss	'	4,765	7,354	'
Prior service cost/(benefit)	'	-24	-31	'
Total	'	4,741	7,323	'
Components of net periodic benefit cost [Abstract]	'	'	'	'
Service cost	'	743	660	611
Interest cost	'	658	795	944
Expected return on plan assets	'	0	0	0
Amortization of prior service cost/(benefit)	'	-7	-7	-7
Recognized actuarial loss	'	284	200	111
Net periodic benefit cost	'	1,678	1,648	1,659
Estimated amounts that will be amortized from AOCI into net periodic benefit cost in 2014 [Abstract]	'	'	'	'
Actuarial loss	'	160	'	'
Prior service cost/(benefit)	'	-7	'	'
Total	'	153	'	'
Major assumptions used in determining the benefit obligations [Abstract]	'	'	'	'
Discount rate (in hundredths)	'	3.70%	3.40%	'
Rate of compensation increase (in hundredths)	'	2.50%	2.40%	'
Major assumptions used in determining the net benefit cost [Abstract]	'	'	'	'
Discount rate (in hundredths)	'	3.40%	3.40%	4.40%
Rate of compensation increase (in hundredths)	'	2.50%	2.40%	2.80%
Aggregate accumulated benefit obligation	'	24,243	'	'
Benefit payments expected to be paid out of the plans [Abstract]	'	'	'	'
2014	'	824	'	'
2015	'	836	'	'
2016	'	837	'	'
2017	'	858	'	'
2018	'	934	'	'
2019-2023	'	5,681	'	'
SERP [Member]	'	'	'	'
Change in benefit obligation	'	'	'	'
Benefit obligation, beginning of year	'	3,690	4,153	'
Service cost	'	0	0	0
Interest cost	'	41	85	150
Actuarial (gain)/loss	'	-9	88	'
Benefits paid	'	-636	-636	'
Currency translation affect	'	0	0	'
Benefit obligation, end of year	'	3,086	3,690	4,153
Change in plan assets	'	'	'	'
Benefits paid	'	-636	-636	'
Unfunded status	'	-3,086	-3,690	'
Amounts recognized in AOCI [Abstract]	'	'	'	'
Actuarial loss	'	830	958	'
Prior service cost/(benefit)	'	230	287	'
Total	'	1,060	1,245	'
Components of net periodic benefit cost [Abstract]	'	'	'	'
Service cost	'	0	0	0
Interest cost	'	41	85	150
Expected return on plan assets	'	0	0	0
Amortization of prior service cost/(benefit)	'	57	57	57
Recognized actuarial loss	'	118	76	49
Net periodic benefit cost	'	216	218	256
Estimated amounts that will be amortized from AOCI into net periodic benefit cost in 2014 [Abstract]	'	'	'	'
Actuarial loss	'	131	'	'
Prior service cost/(benefit)	'	57	'	'
Total	'	188	'	'
Major assumptions used in determining the benefit obligations [Abstract]	'	'	'	'
Discount rate (in hundredths)	'	1.40%	1.35%	'
Major assumptions used in determining the net benefit cost [Abstract]	'	'	'	'
Discount rate (in hundredths)	'	1.35%	2.40%	3.40%
Benefit payments expected to be paid out of the plans [Abstract]	'	'	'	'
2014	'	731	'	'
2015	'	609	'	'
2016	'	609	'	'
2017	'	609	'	'
2018	'	609	'	'
2019-2023	'	$0	'	'

Foreign_Operations_and_Sales_D

Foreign Operations and Sales (Details) (USD $)

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Revenues from External Customers and Long-Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Total Gross sales

$103,011

$77,992

$61,628

$74,581

[1]

$70,389

[2]

$59,841

$77,142

$70,559

$317,212

$277,931

$254,475

Long-Lived Assets

214,647

'

'

'

193,218

'

'

'

214,647

193,218

180,620

Export sales, included in domestic gross sales

'

'

'

'

'

'

'

'

86,850

32,872

31,605

Major customer (in hundredths)

'

'

'

'

'

'

'

'

18.30%

'

'

Domestic [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenues from External Customers and Long-Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Total Gross sales

'

'

'

'

'

'

'

'

153,202

109,729

83,407

Long-Lived Assets

59,496

'

'

'

44,085

'

'

'

59,496

44,085

34,885

Foreign [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenues from External Customers and Long-Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Total Gross sales

'

'

'

'

'

'

'

'

164,010

168,202

171,068

Long-Lived Assets

155,151

'

'

'

149,133

'

'

'

155,151

149,133

145,735

Europe [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenues from External Customers and Long-Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Total Gross sales

'

'

'

'

'

'

'

'

210,463

150,678

156,814

North America [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenues from External Customers and Long-Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Total Gross sales

'

'

'

'

'

'

'

'

86,974

105,439

75,979

Asia [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenues from External Customers and Long-Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Total Gross sales

'

'

'

'

'

'

'

'

13,800

12,827

10,448

Other [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenues from External Customers and Long-Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Total Gross sales

'

'

'

'

'

'

'

'

$5,975

$8,987

$11,234

[1]

Income from continuing operations includes a gain on sale of an office building of $4,680 and a corresponding tax expense of $1,470 and a benefit of $1,155 due to changes in tax laws.

[2]

Income from continuing operations includes the reversal of a valuation allowance on deferred tax assets of $36,287 and the impact on deferred taxes of a statutory rate change of $1,328.

Commitments_Details

Commitments (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Future minimum commitments under non-cancelable operating lease arrangements [Abstract]	'	'	'
2014	$968	'	'
2015	830	'	'
2016	539	'	'
2017	515	'	'
2018	442	'	'
2019 and thereafter	101	'	'
Total commitments	3,395	'	'
Operating lease expense	1,090	815	644
Future commitments under unconditional purchase obligations [Abstract]	'	'	'
2014	2,171	'	'
2015	598	'	'
2016	0	'	'
2017	0	'	'
2018	0	'	'
Total commitments	$2,769	'	'

Contingencies_Details

Contingencies (Details) (USD $)

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2008

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Lorazepam and Clorazepate [Member]

Lorazepam and Clorazepate [Member]

Lorazepam and Clorazepate [Member]

Lorazepam and Clorazepate [Member]

CasChem [Member]

Berry's Creek Site [Member]

Maybrook Site [Member]

Harriman Site [Member]

Harriman Site [Member]

Harriman Site [Member]

Scientific Chemical Processing (SCP) Superfund Site [Member]

Newark Bay Complex Litigation [Member]

Cosan Clifton, New Jersey Site [Member]

Cosan Carlstadt New Jersey Site [Member]

Plaintiff

Indemnification Agreement [Member]

Surety Bond [Member]

Subsidiary

Minimum [Member]

Maximum [Member]

Site

Components of Environmental Loss Accrual [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Estimated remediation expense

'

'

'

'

'

'

'

'

'

'

$2,000

$7,000

'

'

'

'

Reserve for estimated environmental and remediation costs

10,881

5,096

'

'

'

'

249

249

322

3,690

'

'

1,250

324

1,259

1,136

Payments against reserves for estimated environmental and remediation costs

1,670

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Adjustment to environmental and remediation reserves

7,434

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Impact of currency translation on environmental and remediation reserves

21

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of former subsidiaries for which notice was received

'

'

'

'

'

'

'

2

'

'

'

'

'

'

'

'

Approximate number of other sites named PRP of SCP Superfund Site

'

'

'

'

'

'

'

'

'

'

'

'

130

'

'

'

Amount expected to be covered by insurance

'

'

'

'

'

'

'

'

'

'

'

'

735

'

'

'

Loss Contingencies [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of plaintiffs in unresolved case

'

'

4

'

'

'

'

'

'

'

'

'

'

'

'

'

Judgment amount against Mylan, Gyma and Cambrex, payable jointly and severally

'

'

'

19,200

'

'

'

'

'

'

'

'

'

'

'

'

Punitive damages award

'

'

'

16,709

'

'

'

'

'

'

'

'

'

'

'

'

Loss contingency, prejudgment interest

'

'

'

7,500

'

'

'

'

'

'

'

'

'

'

'

'

Payment in exchange for release and full indemnity against future cost or liabilities

'

'

'

'

12,415

'

'

'

'

'

'

'

'

'

'

'

Surety bond amount

'

'

'

'

'

$66,632

'

'

'

'

'

'

'

'

'

'

Discontinued_Operations_Detail

Discontinued Operations (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Discontinued Operations [Abstract]	'	'	'
Pre tax charges for environmental remediation related to sites of divested businesses	($6,708)	($1,425)	($2,851)
Tax effect of discontinued operation - remediation charges	$2,348	$499	'

Gain_on_Sale_of_Asset_Details

Gain on Sale of Asset (Details) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Gain on Sale of Asset [Abstract]	'	'	'	'
Gain on the sale of an office building	$4,680	$4,680	$0	$0
Approximate proceeds from sale of office building	'	1,900	'	'
Approximate secured note received from sale of office building	'	$3,200	'	'

SELECTED_QUARTERLY_FINANCIAL_A2

SELECTED QUARTERLY FINANCIAL AND SUPPLEMENTARY DATA - UNAUDITED (Details) (USD $)	3 Months Ended																12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013		Sep. 30, 2013		Jun. 30, 2013		Mar. 31, 2013		Dec. 31, 2012		Sep. 30, 2012		Jun. 30, 2012		Mar. 31, 2012		Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Summary of selected quarterly financial and supplementary data [Abstract]	'		'		'		'		'		'		'		'		'	'	'
Gross Sales	$103,011		$77,992		$61,628		$74,581	[1]	$70,389	[2]	$59,841		$77,142		$70,559		$317,212	$277,931	$254,475
Net revenues	103,036		77,452		62,803		74,885	[1]	69,930	[2]	59,210		77,133		70,228		318,176	276,501	255,653
Gross profit	33,938		24,966		19,251		24,749	[1]	21,083	[2]	18,531		28,445		22,428		102,904	90,487	74,084
Income from continuing operations	9,440		6,274		3,136		11,425	[1]	44,242	[2]	2,021		9,928		7,038		30,275	63,229	13,735
Loss from discontinued operations	-541	[3]	-2,700	[3]	-862	[3]	-257	[1],[3]	-594	[2],[3]	-332	[3]	0	[3]	0	[3]	-4,360	-926	-2,767
Net income	8,899		3,574		2,274		11,168	[1]	43,648	[2]	1,689		9,928		7,038		25,915	62,303	10,968
Earnings per share of common stock [Abstract]	'		'		'		'		'		'		'		'		'	'	'
Basic (in dollars per share)	$0.29	[4]	$0.12	[4]	$0.07	[4]	$0.37	[1],[4]	$1.46	[2],[4]	$0.06	[4]	$0.34	[4]	$0.24	[4]	$0.86	$2.10	$0.37
Diluted (in dollars per share)	$0.29	[4]	$0.12	[4]	$0.07	[4]	$0.36	[1],[4]	$1.42	[2],[4]	$0.06	[4]	$0.33	[4]	$0.24	[4]	$0.84	$2.06	$0.37
Average shares [Abstract]	'		'		'		'		'		'		'		'		'	'	'
Basic (in shares)	30,353		30,184		30,089		29,970	[1]	29,874	[2]	29,711		29,623		29,602		30,150	29,703	29,468
Diluted (in shares)	31,166		31,052		30,956		30,788	[1]	30,717	[2]	30,587		29,912		29,886		30,901	30,314	29,564
Deferred tax asset valuation allowance change in amount	'		'		'		'		36,287		'		'		'		'	'	'
Deferred tax assets, statutory rate change	'		'		'		'		1,328		'		'		'		'	'	'
Gain on the sale of an office building	'		'		'		4,680		'		'		'		'		4,680	0	0
Income tax expense on gain on sale of office building	'		'		'		1,470		'		'		'		'		'	'	'
Income tax benefit due to changes in tax laws	'		'		'		$1,155		'		'		'		'		'	'	'
[1]	Income from continuing operations includes a gain on sale of an office building of $4,680 and a corresponding tax expense of $1,470 and a benefit of $1,155 due to changes in tax laws.
[2]	Income from continuing operations includes the reversal of a valuation allowance on deferred tax assets of $36,287 and the impact on deferred taxes of a statutory rate change of $1,328.
[3]	Discontinued operations include charges for environmental remediation related to sites of divested businesses.
[4]	Earnings per share calculations for each of the quarters are based on the weighted average number of shares outstanding for each period. As such, the sum of the quarters may not necessarily equal the earnings per share amount for the year.

SCHEDULE_II_VALUATION_AND_QUAL1

SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Doubtful trade receivables and returns and allowances [Member]	'	'	'
Valuation and qualifying accounts [Roll Forward]	'	'	'
Balance Beginning of Year	$652	$450	$1,083
Charged/(Credited) to Cost and Expenses	433	193	-103
Charged/(Credited) to Other Accounts	27	12	-39
Deductions	54	3	491
Balance End of Year	1,058	652	450
Deferred tax valuation allowance [Member]	'	'	'
Valuation and qualifying accounts [Roll Forward]	'	'	'
Balance Beginning of Year	29,941	77,571	77,849
Charged/(Credited) to Cost and Expenses	-97	-45,105	-9,546
Charged/(Credited) to Other Accounts	46	-2,525	9,268
Deductions	'	0	0
Balance End of Year	$29,890	$29,941	$77,571